ALTERNATIVE TRANSCRIPTION AND SPLICING OF DUPLICATED mitf GENES IN THE FISH MEDAKA by ZHU FENG
  
 
ALTERNATIVE TRANSCRIPTION AND 










A THESIS SUBMITTED FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
DEPARTMENT OF BIOLOGICAL SCIENCES 











I hereby declare that this thesis is my original work and it has been written 
by me in its entirety. I have duly acknowledged all the sources of information 
which have been used in the thesis. 
 












Work presented in this thesis was accomplished at the Department of 
Biological Sciences, National University of Singapore from August 2011 
to August 2015. I am very happy to have this opportunity to acknowledge 
everyone who made this work possible. 
This thesis would not have been possible without the support and 
supervision of my PhD advisor, Prof. Hong Yunhan. I really appreciate 
his support and help to broaden my vision and push towards excellence. 
I would also like to express my thanks to the thesis advisory committee 
members, Prof. Chan Woon Khiong and Prof. Yue Genhua for their 
very useful advice and comments. 
I would like to thank all my labmates, Dr. Li Mingyou, Dr. Guan 
Guijun, Dr. Yuan Yongming, Dr. Lin Fan, Dr. Wang Tiansu, Chen 
Jianbin, Zhang Xi and Liu Qizhi. We had a good atmosphere in the lab 
and we made a good team. This made my candidature more fun.  
Furthermore, I would like to appreciate the President's Graduate 
Fellowship for releasing me from any financial problems. 
Finally, I would like to thank my wonderful family for their unconditional 
love and support without which I could not have pursued my dreams. 
Singapore, 12th Aug 2015 
v 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS ................................................................ iv 
SUMMARY ..................................................................................... viii 
LIST OF TABLES ............................................................................. xi 
LIST OF FIGURES .......................................................................... xii 
LIST OF ABBREVIATIONS ........................................................... xiii 
Chapter 1: Introduction ................................................................... 1 
1.1Alternative transcription and 
splicing ..................................................................................................... 2 
1.2Mitf as an example of alternative transcription and 
splicing ..................................................................................................... 6 
1.3Whole genome duplication (WGD) in fish and alternative 
splicing ................................................................................................... 11 
1.4Medaka model to study alternative mitf transcription and 
splicing ................................................................................................... 15 
1.5RNA-Seq for revealing alternative transcription and 
splicing ................................................................................................... 16 
1.6Significance and 
objective ................................................................................................. 17 
Chapter 2: Materials and Methods ............................................... 19 
2.1 Fish and chemicals .......................................................................... 20 
2.1.1 Fish ............................................................................................. 20 
2.1.2 Chemicals ................................................................................... 20 
2.2 Molecular cloning work ................................................................... 20 
2.2.1 Agarose gel electrophoresis ..................................................... 20 
2.2.2 RNA extraction ........................................................................... 20 
2.2.3 Purification of DNA from agarose gel or enzyme reaction 
solution................................................................................................ 21 
2.2.4 cDNA library synthesis .............................................................. 21 
2.2.5 Rapid amplification of cDNA ends (RACE) .............................. 22 
2.2.6 RT-PCR ....................................................................................... 22 
2.2.7 Real-time RT-PCR ...................................................................... 23 
2.2.8 droplet digital PCR (ddPCR) ...................................................... 24 
2.2.9 Cloning ....................................................................................... 24 
2.2.10 Automated sequencing analysis............................................. 25 
2.2.11 Plasmids ................................................................................... 25 
2.3 in situ hybridization ......................................................................... 27 
vi 
 
2.4 Cell culture and transfection ........................................................... 28 
2.5 Luciferase reporter assay ................................................................ 29 
2.6 Microinjection and western blot ...................................................... 30 
2.7 Microscopy ....................................................................................... 31 
2.8 Statistical analysis ........................................................................... 31 
2.9 Transcriptome sequencing ............................................................. 31 
2.10 Bioinformatics analysis of RNA-Seq ............................................ 32 
2.10.1 Quality assessment and filter of raw reads ............................ 32 
2.10.2 Alignment/Mapping reads to genome..................................... 32 
2.10.3 Quality assessment of alignments ......................................... 33 
2.10.4 Assembly of transcripts .......................................................... 33 
2.10.5 Generation of transcriptome assembly .................................. 33 
2.10.6 Counting the transcripts ......................................................... 33 
2.10.7 Annotation of transcripts ........................................................ 34 
Chapter 3: Results ......................................................................... 35 
3.1 Differential evolution of duplicated fish mitf genes ....................... 36 
3.1.1 Medaka Mitf1 and Mitf2 correspond to mammalian MitfA and 
MitfM .................................................................................................... 36 
3.1.2 Medaka mitf1 and mitf2 differ in sequence divergence rate ... 41 
3.1.3 Medaka mitf1 and mitf2 genes are the products of WGD ........ 43 
3.1.4 Medaka mitf1 and mitf2 differ in the expression level ............. 44 
3.1.5 Medaka mitf1 and mitf2 differ in embryonic melanocytic 
expression ........................................................................................... 46 
3.1.6 Medaka Mitf2 possesses a reduced melanogenic activity ...... 47 
3.1.7 Medaka Mitf2 possesses a reduced melanocyte-inducing 
activity ................................................................................................. 50 
3.2 Complimentary approaches for investigation of AT and AS......... 50 
3.2.1 Rapid amplification of cDNA Ends (RACEs) ............................ 50 
3.2.2 RNA-Seq ..................................................................................... 52 
3.3 Alternative transcription of duplicated fish mitf genes ................. 58 
3.3.1 Medaka mitf1 produces multiple AT isoforms ......................... 58 
3.3.2 Expression of mitf1 and mitf2 AT variants ............................... 61 
3.3.3 Activities of Mitf isoforms on target genes’ promoters ........... 62 
3.3.4 Induction of melanocytes and tyr RNA expression in ES 
cells ..................................................................................................... 66 
3.3.5 Activities of Mitf isoforms on the expression of cell lineage 
markers ............................................................................................... 67 
3.3.6 Expression and stability of Mitf protein isoforms ................... 69 
3.4 Alternative splicing of duplicated fish mitf genes ......................... 73 
Chapter 4: Discussion ................................................................... 77 
vii 
 
4.1 Gene duplication and differential evolution ................................... 78 
4.2 Differential evolution of mitf genes ................................................ 81 
4.3 AT and the role of mitf genes .......................................................... 85 
4.3.1 Conserved mechanism of AT of mitf ........................................ 85 
4.3.2 Role of mitf due to differential expression or differential activity
 ............................................................................................................. 86 
4.4 AS and the role of mitf genes .......................................................... 89 
4.5 Conclusions ..................................................................................... 91 
References ..................................................................................... 93 







Alternative transcription (AT) and alternative splicing (AS) represent a 
hallmark of eukaryotic evolution. This thesis work focused on AT and AS 
by using microphthalmia-associated transcription factor (mitf) as a model 
gene. Mitf is a basic helix–loop–helix leucine zipper transcription factor 
that is conserved in the animal kingdom. It acts as the master regulator 
of normal pigment cells and also of cancerous pigment cells. Mitf 
mutations cause Waardenburg syndrome type 2A in human, which has 
defects in skin and eye colour due to melanocyte reduction. Mouse Mitf 
mutations can cause defects in neural-crest-derived melanocytes, 
manifested by a lack of pigment in the coat and inner ear, the latter 
leading to congenital deafness. A few of the mutations also induce 
osteoclasts defects as well as mast cell defects. In mammals, a single 
mitf gene produces multiple RNA variants by differential usage of 
alternative promoters and alternative first exons. In human, 9 alternative 
promoters/first exons are utilized to generate various MITF isoforms with 
unique N-termini including MITF-A, MITF-B, MITF-H and MITF-M. In fish, 
whole genome duplication (WGD) also provides more transcripts or 
protein isoforms. In this work, medaka (Oryzias latipes) is used as a 
ix 
 
lower vertebrate model. Medaka has two mitf genes, mitf1 and mitf2. 
This thesis has identified mitf1 and mitf2 differential evolution after WGD 
by examining their sequence divergence, differential expression and 
differential activity. To further investigate into AT and AS of mitf genes, 
RACE (Rapid Amplification of cDNA Ends) and RNA-Seq were 
employed. We have identified 5’ and 3’ transcript variants of mitf1 via AT 
and AS, respectively. The results of RT-PCR prove differential 
expression of these mitf AT variants in different organs and stages of 
development. Isoforms predicted from these mitf1 AT variants differed 
dramatically in activating target gene expression. Intriguingly, these 
mitf1 isoforms possess considerable differences in inducing the 
expression of multiple cell lineage marker genes. These results 
demonstrate that AT is a conserved mechanism controlling mitf 
expression in vertebrates ranging from human to fish, and that different 
mitf AT isoforms possesses different activities. Interestingly, mitf2 has a 
single promoter and thus lacks AT but is able to produce 2 AS variants. 
We have also proven the differential expression of AS variants in both 
mitf1 and mitf2. Thus, the duplicated medaka mitf genes show a 
considerable difference in the retention and loss of AT and AS during 
their evolution. This finding sheds new lights on differential evolution 
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Chapter 1: Introduction 
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1.1 Alternative transcription and splicing 
In recent years, with the application of genome wide analysis, the 
traditional approach of “one gene→one mRNA→one protein” has 
become an over-simplification. Wide-spread applications of high-
throughput experiments, such as exon arrays and NGS (Next 
Generation Sequencing), have made us realized the prevalence of 
alternative transcription and splicing in almost all multi-exon genes (Pal 
et al., 2011; Sultan et al., 2008). In fact, 90% of the protein-coding genes 
use alternative transcriptional and alternative splicing events (Pan et al., 
2008). For mammals, this number can reach 95% for alternative splicing 
event. In Drosophila melanogaster, 60% of genes undergo alternative 
splicing (Graveley et al., 2011).  
Broadly speaking, alternative transcription and splicing consists of 
four categories, which are alternative transcription initiation, alternative 
splicing, alternative polyadenylation and alternative translation initiation 
(de Klerk and Hoen, 2015). For alternative transcription initiation, it could 
be divided into alternative first exons (AFEs) and alternative 5’UTR 
(A5UTR). As shown in Figure 1.1, cell- and tissue-specific AT transcripts 
are regulated by the binding of transcription factors (TFs) to promoters 
and enhancer regions. In some cases, whereas enhancers are located 
within the coding region, others are located in intergenic regions or within 
intronic regions of other genes (Hill and Lettice, 2013).  
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Figure 1.1. Alternative transcription initiation.  
Alternative transcription initiation can be divided into (A). Alternative first 
exons and (B) Alternative 5’UTR. (C) Cell- and tissue-specific AT 
transcripts are regulated by the binding of transcription factors (TFs) to 
promoters and enhancer regions. (D) Long-range transcriptional control 




Figure 1.2. Alternative splicing events. Five major AS events are 
illustrated, including (A) Exon skipping (ES), (B) Alternative 3’ splice site 
selection(A3SS), (C) Alternative 5’ splice site selection (A5SS), (D) 
Intron retention (IR) and (E) Mutually exclusive exons (MXE). 
Constitutive exons are shown in blue and alternatively spliced regions in 
purple. Introns are represented by solid lines, and dashed lines indicate 




As shown in Figure 1.2, alternative splicing (AS) events can be 
classified into four main subgroups (Keren et al., 2010). The first type is 
exon skipping (ES), in which an exon is skipped together with its flanking 
introns so that it does not appear in the final transcript (Figure 1.2A). 
Exon skipping can account for nearly 40% of higher eukaryotes AS 
events (Alekseyenko et al., 2007). The second and third types are 
alternative 3’ splice site (A3SS) and 5’ splice site (A5SS) (Figure 1.2B 
and C). These types of AS events occur when two or more splice sites 
are recognized at one end of an exon. A3SS and A5SS constitutes of 
18.4% and 7.9% of all AS events in higher eukaryotes, respectively. The 
fourth AS event is intron retention (Figure 1.2D), in which the mature 
mRNA transcript includes an intron. This is the rarest AS event in 
vertebrates and invertebrates (Alekseyenko et al., 2007), but is the most 
common AS in plants (Kim et al., 2008). The last category includes 
mutually exclusive exons (Figure 1.2E), which is rare and more complex 
(Black, 2003).  
Alternative splicing is regulated by splicing silencers which would 
interfere the recognition of strong and weak splice sites (SS) by small 
nuclear ribonucleoprotein (snRNP) splicing factor (Yu et al., 2008). 
Usually snRNPs recognize both strong and weak SS but splicing occurs 
only at the strong SS. However, with the existence of a splicing silencer 
sequence (SSS) located downstream of the strong SS, only the weak 
SS is used for splicing.  
Alternative splicing can also be regulated by RNA secondary 
structures. When the short-range or long-range RNA secondary 
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structure masks the strong SS, a weaker SS can be recognized 
(Pervouchine et al., 2012). 
The event of alternative promoter usage and/or alternative splicing 
results in a plethora of transcript variants corresponding to a single gene, 
which greatly evolves the generation of transcriptome and proteome 
complexity. The resultant transcript variants may remain as non-coding 
transcripts or be translated to different proteins that diverge in structure, 
activity or even functions. These differed proteins are called isoforms. 
For example, SRA1 produces both non-coding RNA and protein 
isoforms of steroid receptor RNA activator (Ulveling et al., 2011), and 
multiple BDNF transcript variants differing in the first exonic sequence 
translate the same BDNF protein (Pruunsild et al., 2007). The difference 
between AT and AS is that in AT, isoforms are produced by several pre-
mRNAs, whereas in AS, isoforms all arise from a single pre-mRNA but 
in different splicing patterns. In this thesis work, we mainly focus on one 
specific AT event, usage of alternative promoters, which produces AFEs. 
AS events are also being studied. 
1.2 Mitf as an example of alternative transcription and splicing 
One of the best examples for alternative transcription perhaps is mitf, 
a highly conserved gene essential for pigment cells in diverse animal 
species. 
The microphthalmia-associated transcription factor (mitf) encodes a 
basic helix–loop–helix leucine zipper transcription factor whose major 
role in vertebrates is to act as the master regulator of melanin-bearing 
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pigment cells (Hodgkinson et al., 1993; Widlund and Fisher, 2003). For 
instance, Human MITF regulates melanocytes at specification, 
proliferation, survival, migration, differentiation and malignant 
transformation. It regulates retinal pigment epithelium (RPE) cells at the 
level of developmental specification, proliferation and function in retinal 
physiology. Mutation of MITF causes Waardenburg syndrome (WS) type 
IIA which has melanocytic deficiencies in the eye, forelock and inner ear 
(Tassabehji et al., 1994). Common to nearly all Mitf mutations in the 
mouse are defects in neural-crest-derived melanocytes, manifested by 
a lack of pigment in the coat and inner ear (Hallsson et al., 2000; 
Steingrimsson et al., 1994; Tsujimura et al., 1996). Most mutations also 
produce defects in retinal pigment epithelial cells, which in turn results in 
abnormal eye development. A few of the mutations also induce 
osteoclast defects, which can lead to severe osteoporosis, as well as 
mast cell defects (Roundy et al., 2003) 
Genomic sequencing of mitf in vertebrates has revealed a complex 
intron-exon structure with several widely spaced 5’ exons, which are 
expressed from different promoters, giving rise to protein products with 
different N-termini (Amae et al., 1998). In mammals, a single mitf gene 
produces multiple RNA variants by differential usage of alternative 
promoters and alternative first exons (Bharti et al., 2008; Hallsson et al., 
2000; Hershey and Fisher, 2005; Steingrimsson et al., 2004). In addition 
to alternative usage of 5’ exons, splice forms have been described that 
would lead to different Mitf proteins through the alternative uses of exons 
2 through 9 (Takemoto et al., 2002; Udono et al., 2000). 
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In human, the MITF generates 4 ncRNAs and 13 protein-coding 
variants 
(http://asia.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=E
NSG00000187098), and a total of 9 alternative promoters/first exons are 
known to generate various MITF isoforms with unique N-termini (Hou 
and Pavan, 2008). As shown in Figure 1.3, nine different promoters 
present in a 200kb region, assigning AFEs for each isoform. To better 
understand the how AFEs affect protein isoforms, the structure of MITF 
protein isoforms are shown. Generally speaking, AFEs will determine the 
5’ specificity of isoforms. However, in some cases, alternative first exon 
usage can lead to same isoform production. For MITF-J, MITF-E and 
MITF-D, as they do not have ATG in their first exons, they share a 
common translated protein. Despite that, all isoforms share the same 
exons 2 to exon 9, where the functional domains reside (Udono et al., 
2000), including the activation domain (AD) and the b-HLH-Zip involved 
in homo- or hetero-dimerization with the related TFs: TFE3, TFEB, and 
TFEC (Hallsson et al., 2007; Sato et al., 1997).  
Some Conserved domain (CD) presents in some exons to serve as 
DNA-binding site or has regulatory functions (Hallsson et al., 2007). 
Furthermore, Mitf is also modified at some specific sites in the post-
translational process, particularly phosphorylation by mitogen-activated 
protein kinase (MAPK) and glycogen synthase kinase-3b (GSK3b) 
(Hemesath et al., 1998; Takeda et al., 2000). These phosphorylation 
enhances the transcriptional activity of MITF.These kinases reside within 
various important homeostatic signalling pathways and might therefore 
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modulate Mitf transcriptional activity in response to specific 
environmental cues. MITF can be subjected to USP13-mediated 
deubiquitylation, thus preventing MITF from proteasomal degradation 
(Hartman and Czyz, 2015). In addition, MITF can be a target for other 
modifications, including SUMOylation (Murakami and Arnheiter, 2005) 




Figure 1.3. Organization of human MITF gene.  
(A). Genomic organization of human MITF gene. Nine different 
promoters/first exons of MITF are located throughout a region over 
200kb while exons 2 to 9 are common. (B) Protein structure alignment 
of human MITF. The isoform-specific first exons (pink) are spliced to 
exon 1B1b (red) and then to the common exons 2–9 (grey), except for 
MITF-M. 7 isoforms are produced. Functional domains (AD, 
transactivation domain and b-HLH-Zip, basic/helix-loop-helix/leucine 
zipper) and some conserved domains (CD, conserved domain) are 
marked in yellow. (C). Structure of MITF-M, showing function domains 
and regulatory sites including phosphorylation, deubiquitylation, 
SUMOylation and Caspase-mediated cleavage. Adopted from (Hartman 
and Czyz, 2015) 
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Notably, human MITF isoforms show differential expression patterns. 
For example, MITF-A is expressed in a wide variety of organs including 
the eye and cartilage, and MITF-M is expressed preferentially in the 
neural crest and its pigment cell derivatives, where it acts as the master 
regulator of melanocytes, because its forced expression is sufficient to 
induce melanocyte formation in differentiated cells of mammals and 
embryonic stem (ES) cells of the fish medaka (Bejar et al., 2003). 
1.3 Whole genome duplication (WGD) in fish and alternative 
splicing 
In contrast to alternative transcription, it has been shown that fish has 
undergone a specific evolution and as a result, two Mitf proteins 
corresponding to the mouse MitfA and MitfM were generated 
(Altschmied et al., 2002; Braasch et al., 2009a). Gene duplication is a 
major force of evolution and plays a critical role in increasing complexity, 
and two rounds of whole genome duplication (WGD) have been 
proposed to occur during vertebrate evolution (Ohno et al., 1968). As 
shown in Figure 1.4, through the ancient WGD in the fish lineage ~350 
million years ago (Yamanoue et al., 2006), many fish species have two 
or even more distinct genes that are homologous/paralogous to a single 
gene in mammals and birds.  
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Figure 1.4. Whole Genome Duplication (WGD) in fish. The teleost 
lineage splits from basal ray-finned fishes and started to diverge after a 
WGD event that took place 320–350 mya. For some fish species such 
as salmon and common carp, they have even more rounds of WGD. 





Figure 1.5. Evolutionary fate of single gene duplications. Single 
gene duplication most often results in a nonfunctional duplicate gene 
copy (A, nonfunctionalization). (B) In rare instances, the functional 
duplicate gene copy and the ancestral gene diverge in function; 
neofunctionalization means that one of the two genes retains the original 
function, while the other evolves a new, often beneficial function. 
Subfunctionalization implies that both the original and the duplicate 
genes mutate and evolve to full complementary functions already 
present in the original gene. Duplication via retrotransposition represents 
a particular case of sub- or neofunctionalization. (C). If there is no 
functional divergence, genetic robustness will be increased. Adopted 




Duplicated genes may adopt three major modes of evolutionary 
divergence: loss by deleterious mutations (nonfunctionalization) (Figure 
1.5A), acquisition of a new adaptive function (neofunctionalization) or 
division of an ancestral function (subfunctionalization) (Figure 1.5B). 
Neofunctionalization means that one of the two genes retains the original 
function, while the other evolves a new, often beneficial function. 
Subfunctionalization implies that both the original and the duplicate 
genes mutate and evolve to full complementary functions already 
present in the original gene. Duplication via retrotransposition represents 
a particular case of sub- or neofunctionalization. If there is no functional 
divergence, genetic robustness will be increased.  
From the above introduction we know that both alternative splicing 
and gene duplication contribute to the proteomic functional diversity. 
Studies on the relation between AS and gene duplication across species 
(Abascal et al., 2015; Su et al., 2006) all support a function-sharing 
model that some proteomic components can be performed either by 
alternatively spliced genes or duplicate genes. 
In fish, mitf has been identified in ~40 species, and the presence of 
two mitf genes has been documented in several model fish species 
including fugu, pufferfish, Xiphophorus (Altschmied et al., 2002) and 
zebrafish (Lister et al., 2001; Lister et al., 1999). The two zebrafish mitf 
genes differ in the first exon just as mammal isoforms of mitf. Nacre 
mutation of mitfa affects the development of pigment cells on the skin 
but not in the eye, leading to absence of melanocyte lineage cells. The 
eye pigmentation is controlled by mitfb, which is mainly expressed in, 
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and required for, RPE development. Interestingly, ectopic expression of 
mitfb can rescue the pigment phenotype of mitfa mutant (Lister et al., 
2001; Lister et al., 1999). Therefore, in zebrafish, the two mitf genes 
have undergone subfunctionalization to provide complementary 
expression and functions in pigmentation (Altschmied et al., 2002; Lister 
et al., 2001). The zebrafish studies have also provided the first evidence 
that differential expression but not protein structure of the mitf isoforms 
largely determines the ultimate mitf role in pigmentation.Medaka model 
to study alternative mitf transcription and splicing. 
In this thesis work, Medaka (Oryzias latipes) serves as a good model 
to study pigment cell biology, function and evolution of mitf genes in fish. 
The small laboratory fish is one excellent lower vertebrate model for 
analyzing development (Wittbrodt et al., 2002) and in particular, 
pigmentation biology. Compared to mammals, medaka has four types of 
pigmented cells (melanophore, leucophore, iridophore and xanthophore) 
instead of only one (melanocyte). There are more than 40 inbred lines 
and mutant strains showing diverse pigmentation patterns and 
abnormalities(Kelsh et al., 2004). In medaka, several pigmentation-
related genes have been identified, including tyrosinase(Koga and Hori, 
1997), Oca2 (Fukamachi et al., 2001), somatolactin (Fukamachi et al., 
2004) and vps11 (Yu et al., 2006). Furthermore, cell lines of medaka ES 
cell (Hong et al., 1996) and male germ stem cell (Hong et al., 2004) have 
been established for studying pigment cell development in vitro.  
Medaka has two mitf genes, mitf1 and mitf2, which encode mitf1 and 
mitf2 that correspond to the mouse MitfA and MitfM, respectively, on the 
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basis of gene structure, chromosome synteny and phylogenetic 
sequence comparisons. 
Above all, medaka is a perfect tool to study alternative mitf 
transcription and differential activity. 
Previous studies in our lab have identified two medaka mitf genes, 
mitf1 and mitf2. Mitf is a transcriptional activator of medaka germline 
genes (Zhao et al., 2012) and both mitf1 and mitf2 RNAs are a 
component of the Balbiani’s body (Li et al., 2013a), which is a transient 
structure in the developing oocyte and thought of as being a stage-
specific equivalent of germ plasm (Xu et al., 2010).  
1.4 RNA-Seq for revealing alternative transcription and splicing  
In the past ten years, with the development of technologies in 
sequencing broadens our vision on alternative transcription and 
alternative splicing, especially in a genome-wide manner. Compared to 
tilling array and EST sequencing, RNA-Seq has the invaluable 
advantage of high resolution and throughput and also has low required 
amount of RNA and low cost. 
RNA-Seq has the power to give us the number of AT and AS 
transcripts, the structure of each transcript (i.e. how each transcript is 
formed by AT and AS process) and also the abundance of transcripts all 
in the same process. To a deeper extent, even the molecular 
mechanisms that form the transcripts can be elucidated. A thorough 
comparison of RNA-Seq platforms is reviewed in (van Dijk et al., 2014). 
In my study, I choose the most widely used and cost-effective platform: 
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HiSeq from illumima. In this way, my raw data would be pair end short 
reads.  
The power of RNA-Seq to reveal AT and AS depends on a crucial step: 
transcriptome reconstruction. This step is to define a precise map of all 
transcripts that are expressed in the sample sequenced. It requires the 
assembly of read alignments. This is a difficult computational task due 
to the divergence of gene expression profile, existence of premature 
mRNA contamination and determination of short read alignment if many 
isoforms exist. One strategy to do this reconstruction is called Reference 
Annotation Based Transcript (RABT), which firstly provides a reference 
genome to mapping all the reads to it and then assembles overlapping 
reads into transcripts (Trapnell et al., 2012). This method was widely 
used and examined. 
Researchers are now utilizing the power of RNA-Seq to investigate 
into more specific biological questions including the quantification of 
alternative splicing events in tissues (Cui et al., 2012; Wang et al., 2008), 
populations (Blekhman et al., 2010) and disease (Gamazon and 
Stranger, 2014; Wilhelm et al., 2011).  
1.5 Significance and objective 
mitf is a pleiotropic factor, because its mutations cause a variety of 
abnormality including pigmentation-related diseases, melanomas and 
cartilage defects. In mammals, mitf represents a family of isoforms 
generated by alternative promoter choice and alternative splicing. In fish, 
whole genome duplication also provides more transcripts or protein 
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isoforms. It is unknown whether alternative transcription is a mechanism 
for mitf expression that is unique to mammals or common to vertebrates, 
as no report on alternative transcription has been described for mitf in 
lower vertebrates. Furthermore, the pigmentary cell lineage comprises 
solely of melanocytes in mammals but 4 distinct pigment cells in fish, 
namely melanophores, iridophores, xanthophores and leucophores 
(Kelsh et al., 2004), making more potential target genes of mitf. More 
importantly, it is also unknown whether distinct Mitf roles are due to 
differential expression and/or varying activities of different isoforms.  
The objective of this thesis is to answer three biological questions. The 
first aim is to reveal the differential evolution of fish duplicated mitf genes 
after WGD. The second aim is to test that AT and AS of mitf also exists 
in fish. The third is to explore whether that differentially expressed mitf 
isoforms have overt differences in activity and specificity of inducing 
target genes. One or more dominant isoforms will reveal their role in 
particular organs or stages of development, leading to discoveries of 
new target genes or upstream regulating genes and connecting mitf to 
new signalling pathways. To achieve these goals, molecular cloning, 
transcriptome analysis, gene expression profile，reporter assay and 
















2.1 Fish and chemicals 
2.1.1 Fish 
Work with fish followed the guidelines on the Care and Use of Animals 
for Scientific Purposes of the National Advisory Committee for 
Laboratory Animal Research in Singapore (Protocol Number: 067/12). 
Medaka strains HdrR and HB32C were maintained under an artificial 
photoperiod of 14-h/10-h light/darkness at 26°C as described (Hong et 
al., 2011). 
2.1.2 Chemicals 
In this study, chemicals were purchased from Sigma (MO, USA) 
unless otherwise indicated. Deionized water was collected from 
PURELAB Prima system (ELGA Lab). Ultrapure water was collected 
from Milli-Q Water Purification Systems (Merck Millipore). 
2.2 Molecular cloning work 
2.2.1 Agarose gel electrophoresis 
For agarose gel electrophoresis, 1.0% or 1.5% agarose gels were 
casted with 1×GelRed DNA stain (Biotium). For each well, 2-5 μl sample 
with Loading Buffer (Takara) was loaded. The gels were run at 5-8V/cm 
in 1×TAE buffer (0.04 M Tris-base, 0.02 M acetic acid, 0.01 M EDTA, pH 
8.0) with Horizontal Electrophoresis Systems (Bio-Rad). 
2.2.2 RNA extraction 
Total RNA isolated from adult fish organs or developing embryos was 
extracted by using the Trizol reagent (Invitrogen) following the 
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manufacturer’s instruction. 100 mg sample with the addition of 1 ml 
TRIzol was homogenized in 1.5 ml EP tube with a homogenizer on ice 
(Sigma). For the final step, RNA samples were dissolved in 20 μl RNase-
free water. RNA quality were checked by using agarose gel 
electrophoresis and concentration were assessed on a WPA Biowave II 
UV/Visible Spectrophotometer from Biochrom (Cambridge, UK). For 
samples for next-generation sequencing, RNA quality and concentration 
were assessed using Agilent 2100 Bioanalyzer (Agilent Technologies) 
and CYTATION 3 Cell Imaging Multi-Mode Reader (Bio Tek). After that, 
~15 ug of total RNA dissolved in 40 μl water was sent to BGI TECH 
SOLUTIONS (HONGKONG) CO., LIMITED (Hong Kong, China). 
2.2.3 Purification of DNA from agarose gel or enzyme reaction 
solution 
For purification of DNA from agarose gel, DNA bands of interest were 
identified and cut under UV light and weighed in an EP tube. For 
purification of DNA from enzyme digestion or other reaction, there was 
no such prior step. DNA ready for purification was then applied to MN 
NucleoSpin Gel and PCR Clean-up Kit (MACHEREY-NAGEL) following 
manufacturer’s instructions. 
2.2.4 cDNA library synthesis 
For RT-PCR validation, the cDNA libraries were synthesized from 2 
μg of RNA extracted using Maxima First Strand cDNA Synthesis Kit (Life 
technologies) following the manufacturer’s instruction. Synthesis of 
SMART cDNA libraries was primed with oligo (dT)8-12 by using the 
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RACE cDNA Amplification Kit according to the manufacturers’ 
instructions (Clontech). 
2.2.5 Rapid amplification of cDNA ends (RACE)  
For 5’-RACE, the SMART library 5’-adapter primer (5'-
AACGCAGAGTACGCGGGG-3') was used in combination with a gene-
specific primer for a first round PCR, the latter being m1r5 (5'-
CAGCTTGCGGATGTAATCTAC-3') for mitf1 and m2r5 (5'-
TGTTGAACCTTCGCCTTCGTT-3') for mitf2. For 3’-RACE, the primer 
for mitf1 was 5'-CCTCAACTCCAACTGCGAGAAAGAGATGG-3' and 
primer for mitf2 was 5'-ATCAAGGACTAACGCTGTCCAACCTGCCTA-
3' for mitf2. The PCR reaction was conducted on Mastercycler from 
Eppendorf (Hamburg, Germany) in a volume of 50 µl, containing 5 ng of 
a SMART cDNA reaction, 200 µM of four dNTPs, 0.2 µM of each primer, 
and 1 µl Advantage 2 Polymerase Mix (Clontech) . A second round of 
nest PCR was similarly run for 30 cycles by using 1 µl of the first PCR 
reaction and the 5’-adaptor primer together with m1r4 (5'-
TGCCTTTGTTCCAGCGCATGT-3') for mitf1 and m2r4 (5'-
GGCAAGAGCTCTAACCTCAGT-3') for mitf2. PCR products were 
cloned into pGEM-T (Promega) and sequenced. The primers were 
designed with DNAman software from Lynnon Biosoft (San Ramon). 
2.2.6 RT-PCR 
PCR analysis was done as described (Hong et al., 2004b; Yi et al., 
2009). Briefly, PCR was run in a 25-µl volume containing 10 ng of cDNA 
reaction for 30 cycles (β-actin), 36 (mitf1), 38 (mitf1 RNA variants), 40 
(mitf2) or 35 cycles (other genes) of 10 s at 94°C, 15 s at 58°C and 60 s 
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at 72°C. Primers used are listed in Appendices. Primers m1f1 plus m1r1 
and m2f1 plus m2r1 (See Appendices) were used to amplify mitf1 and 
mitf2 RNAs, respectively. The four mitf1 variants were individually 
amplified by using the common 3’ primer 5'-
ACAGCCCTGCTCGTTTTCATCCAT and variant-specific primer for 
mitf1a (M1aF; 5'-ATGCAGTCCGAATCCGGAATA-3'), mitf1b (M1bF; 5'-
ATGACATCACGCATCCTGCTACGC-3'), mitf1h (M1hF; 5'-
ATGGAGGCCATAGGAGTGCAAGTG-3') and mitf1m (M1mF; 5'-
ATGCTTGAGATGCTCGGATAC-3'). The PCR products were separated 
on 1.0% agarose gels and documented with a bioimaging system 
(Synoptics). 
2.2.7 Real-time RT-PCR 
Real-time PCR was performed with SYBR® Green qPCR SuperMix 
(Invitrogen) on the IQ5 real-time PCR detection system (BioRad). The 
primers for detecting were tyr1514F (5'-
TCACCATGCTTTCATTGACAGC-3') and tyr1621R for the medaka tyra, 
mitf1-QF (5'-TCTCCTGCCATCATGCACA-3') and mitf1-QR (5'-
AGCGCTCTTACCTCAGCTTCA-3') for the medaka mitf1, mitf2-QF (5'-
CAACTTGATTGAACGAAGGCG-3') and mitf2-QR (5'-
TGTTCCAGCGCATATCTGGAT-3') for the medaka mitf2, actinqs (5'-
AGAAGAGCTATGAGCTGCCTG-3') and actinqr (5'-
AACATCACACTTCATGATGCTG-3') for the medaka β-actin as a 
internal control. The relative fold change of tyr quantities was calculated 
with 2(-delta delta Ct) method (Livak and Schmittgen, 2001). 
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2.2.8 Droplet digital PCR (ddPCR) 
Quantification of RNA transcripts was performed with QX200 
automated ddPCR system (Bio-rad) strictly following the manufacturer’s 
instructions. Briefly, cDNA templates were first mixed with 2× QX200 
ddPCR EvaGreen Supermix to a total volume of 20 μl. The mixture was 
transferred to the 96-well plate (Eppendorf) and subjected to oil droplets 
generation with the automated generator (Bio-Rad). The oil droplets 
were further amplified with the following set-up: 95 oC for 10 min (1 cycle), 
94 oC for 30 s and 60 oC for 1 min (40 cycles), 98 oC for 10 min (1 cycle) 
and 4 oC until droplet reading. Droplets were read by QX200 Droplet 
Reader (Bio-Rad) and analyzed with the QuantaSoft software (Bio-Rad) 
that determines concentration of target cDNA as copies per microliter 
(copies/μL) from the fraction of positive droplets using Poisson statistics 
(Beliakova-Bethell et al., 2014). The copy number of each mRNA was 
further normalized with β-actin. 
2.2.9 Cloning 
PCR products or other DNA segments of interest were applied to TA-
cloning method for cloning. In our existing PCR system (described 
above), there was no need for a step of 3' A overhang addition prior to 
TA-cloning. pGEM-T Easy vectors (Promega) were used to perform TA-
cloning. After ligation, DNA products were transformed into HIT-
DH5alpha high competent cells (BioAspect) according to manufacturer’s 
guide or self-prepared competent cells originated from strain TOP10F 
(Invitrogen) following protocol from Chapter 3 in Molecular Cloning: A 
Laboratory Manual (Sambrook and Russell, 2001). 
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2.2.10 Automated sequencing analysis 
DNA Sequences were determined by using the BigDye Terminator 
v3.1 Cycle Sequencing Kit on ABI PrismR 3100 Genetic Analyzer 
(Applied Biosystems). Sequence alignment was run on the Vector NTI 
Suite 11 (Invitrogen). 
A phylogenetic tree was constructed by using the DNAMAN software 
(version 4.15, Lynnon Biosoft) from a matrix of pairwise genetic 
distances according to the neighbor-joining (NJ) and minimum evolution 
(ME) methods, and 1,000 trials of bootstrap analyses were used to 
provide confidence estimates for tree topologies. Genomic organization 
and chromosomal locations were investigated by comparing the cDNA 
and corresponding genomic sequence. 
2.2.11 Plasmids 
Five luciferase (Luc) reporter plasmids were used in this study. pGL3-
basic is promoterless and contains the firefly luc (Promega). pTAluc was 
derived by inserting the TATA-containing minimal promoter of the 
Herpes Simplex virus thymidine kinase upstream of luc in pGL3-basic 
(Promega). pDAZluc was described (Zhao et al., 2012a).  To construct 
pDAZluc, the 4.2-kb promoter sequences of the medaka dazl were PCR-
amplified from genomic DNA and inserted into MluI and XhoI sites that 
are upstream of the luc in pGL3-Basic, respectively. The PCR primers 
used were 5’-acgcgTCATCACCCAGTGAGGGTCC-3’ plus 5’-
ctcgaGAATTCTTTCTAAAATGATTAAAACCAAGAATTTGG3’ 
(restriction sites are underlined) for DAZ. To construct pTYRluc, the 3.3-
kb promoter of a medaka tyrosinase gene (tyra; accession number 
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AB010101) was obtained by PCR from genomic DNA with primer 5'-
TTACGCGTAGTGAGTGATGCACCTCTGC-3' and 5'-
TCTCGAGATTCACCCACATCTGTCC-3' (restriction sites are 
underlined) and inserted into MluI and XhoI sites that are upstream of 
the luc in pGL3-Basic. pRL-CMV expresses the Renilla Luc and was 
used as internal reference to calibrate transfection efficiency (Promega). 
Briefly, pXmitf is a derivative of pCMVtkLUC+, in which the luc coding 
sequence was replaced by a fusion of a synthetic DNA fragment 
encoding the myc-tag and the Xiphophorus mitf-M coding sequence 
(Zhao et al., 2012a). Seven expression plasmids were used as 
transfection control or effectors. Plasmids pCVpf and pOmitf2 were 
described, which express the fusion between the puromycin 
acetyltransferase gene and GFP (Zhao et al., 2012a) and the medaka 
mitf2 (Li et al., 2013b). Plasmid pCVpf was constructed by inserting in 
frame the puromycin acetyltransferase gene to gfp in pEGFP-N1 
(Clontech). pOmitf2 was constructed by inserting the medaka mitf2 
cDNAs in frame to the mCherry sequence in pCS2+. pOmitf1a, pOmitf1b, 
pOmitf1h, pOmitf1m and pOmitf1N were constructed by inserting the 
medaka mitf1 cDNAs for isoforms A, B, H and M in frame to the mCherry 
sequence in pCS2+, respectively.  The mitf1 cDNA variants (mitf1a, 
mitf1b, mitf1h, mitf1m and mitf1n) were PCR-amplified by using forward 
primers M1aF, M1bF, M1hF, M1mF and M1nF in combination with a 
common reverse primer M1R (5'-ACAGCCCTGCTCGTTTTCATCCA-3'). 
The cDNAs for the five Mitf1 variants and Mitf2 were inserted between 
BamHI or EcoRI and ClaI site of pCS2cherry, resulting in pOmitf1a:ch, 
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pOmitf1b:ch, pOmitf1h:ch, pOmitf1m;ch, pOmitf1N:ch and pOmitf2:ch, 
which express a fusion between each of Mitf proteins and mCherry. 
Correct cloning was confirmed by test digestion and/or sequencing. 
Plasmid DNA was prepared by using the Plasmid Midprep kit (Qiagen). 
2.3 in situ hybridization 
Antisense RNA probes were synthesized from linearized pGEMtyr, 
pGEMmi1 and pGEMmi2 by using the DIG RNA labeling kit (Roche) as 
described (Li et al., 2011b).  Embryos at stage 29 were subjected to in 
situ hybridization (ISH) with DIG-labeled probe followed by chromogenic 
staining with NBT/BCIP as described (Liu et al., 2009).  Sections were 
subjected to two-color fluorescence in situ hybridization (Hershey and 
Fisher) by using the tyramide signal amplification (TSATM) Plus 
Fluorescence Systems according to the manufacturer’s instruction 
(NEL756, PerkinElmer Life Science) as described (Li et al., 2011b). 
Briefly, after hybridization and blocking as described above, the samples 
were incubated with the POD-conjugated anti-FITC-antibody (Sigma) at 
a 1:2000 dilution for 2 hours at room temperature to detect the FITC-
labeled probes. Following six PBST washes the samples were incubated 
for 30 minutes in the TSA-Fluorecein at a 1:100 dilution in the TSA 
Amplification Buffer (0.004% H2O2 in 0.1 M borate buffer, pH8). The 
samples were then subjected to detection of the DIG-labeled probe: 
They were treated for 1 hour in 1% H2O2 and incubated for two hours 
with the horseradish peroxidase (POD)-conjugated anti-DIG antibody 
(Sigma) at a 1:2000 dilution, followed by a 30-min incubation in TSA-Cy3 
for 30 min. The samples were finally stained for nuclei by using DAPI 
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(µg/ml) and embedded in the Gold Antifade reagent (Invitrogen) for 
microscopy. In this FISH procedure, two differently labeled antisense 
RNA probes are co-incubated with a sample in the hybridization step and 
subjected to sequential color development into green and red 
fluorescence (Li et al., 2011a). 
2.4 Cell culture and transfection 
Plasmid DNA was prepared by using the Qiagen Midi- and Maxi-preps 
kit (Qiagen). The medaka ES cell line MES1 was maintained on gelatin-
coated tissue culture plasticware in medium ESM4 containing 15% fetal 
bovine serum (Hong et al., 1996) and transfected as described (Hong et 
al., 2004a). In this cell line it has previously been shown that pXmitf 
transfection is sufficient to direct melanocyte differentiation (Bejar et al., 
2003). Cells in 24-, 12- and 6-well plates were transfected with 0.5, 1 
and 3 μg of plasmid DNA by using the DNAfectinTM 2200 reagent 
(Applied Biological Materials Inc.) according to the manufacturers’ 
instruction. Each of Mitf-expression plasmids was cotransfected with 
pCVpf at a 1:4 ratio. Control transfection received only pCVpf. 
Appearance of black pigmented melanocytes was monitored from day 3 
post transfection (dpt) onwards. In some experiments, cell transfection 
was followed by drug selection to enrich for transgenic cells. For this, 
cells following cotransfection with pCVpf were grown in the presence of 
puromycin (final 1 μg/ml) for 2 days before harvest for RNA isolation and 
RT-PCR analysis. 
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2.5 Luciferase reporter assay 
For reporter assays, cells were transfected in 96-well plates (Zhao et 
al., 2012b). Briefly, ~30,000 cells were seeded in 96-well plates (Biostar) 
and transfected with 102 ng of plasmid DNA. The following day, cells 
were at ~70% of confluence and transfected. For cotransfection, plasmid 
DNA for each well of 96-well plate contains 2 ng of pRL-CMV as the 
internal reference, 50 ng of a firefly luciferase reporter (pGL3-basic, 
pTAluc, pDAZluc or pTYRluc), 25 ng of Mitf-expressing plasmids or 
pCVpf. For control transfection, each well received 2 ng of pRL-CMV, 50 
ng of a firefly luciferase reporter plasmid and 50 ng of pCVpf. 
Transfection efficiency was monitored by GFP expression from pCVpf in 
a duplicate 96-well plate to be at ~30%. At day 3 or 4 dpt, cells were 
measured for luciferase activity by using the Dual-GloTM Luciferase 
assay kit (Promega) and measured on GlomaxTM 96 Microplate 
Luminometer (Promega). Briefly, each well was replaced by 20 µl of 
fresh medium containing only 9% FBS. The plate was equilibrated at 
room temperature (RT) for 10 min. For measuring firefly luciferase 
activity, 20 µl of Dual-Glo™ Luciferase reagent was added to each well 
and mixed. After incubation at RT for 20 min, the firefly luminescence 
was measured in the GlomaxTM 96 Microplate Luminometer (Promega), 
Subsequently, 20 µl of Dual-Glo™ Stop & Glo® Reagent (1:100 dilution 
of substrate to buffer) was added to each well, mixed, incubated at RT 
for 10 min and measured similarly for the Renilla luciferase activity. The 
ratio between firefly luciferase activity and Renilla luciferase activity was 
used for comparisons. The reading from pGL3-basic was considered as 
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background, and that from pTAluc treated as unit activity. Relative 
luciferase activity from pTYRluc or DAZluc alone or in combination with 
Mitf-expressing plasmids was normalized to that of pCVpf.  
2.6 Microinjection and western blot 
Medaka embryos were injected at the 1-cell stage as described (Li et 
al., 2012). They were injected with each of plasmids for mCherry-tagged 
Mitf isoforms plus pCVpf at a 1:1 ratio (total 25 pg/nl) and analyzed at 
day 2 post fertilization (the mid-gastrula stage). Positive embryos were 
used for protein isolation. Western blot was done as described (Xu et al., 
2005). Briefly, embryos were put in DMSO and dechorioned to remove 
yolk with very sharp forceps. When the yolk has run out, the embryos 
were transferred to a new tube and incubated in RIPA buffer (Pierce) for 
protein isolation. About 30 μg of total protein from the embryos extract 
was subjected to 10% SDS-PAGE Bio-Rad mini Protein electrophoresis 
system. The separated proteins were transferred to a PVDF membrane 
by using the Transblot mini-protein transfer system. The membrane was 
first incubated with anti-mouse mCherry primary antibody (ab125096, 
Abcam) at a dilution 1:2000 in 5% non-fat milk in TBST (100 Mm Tris-Cl, 
pH 7.5, 100Mm NaCl, 0.1% Tween 20) for 1 hour at room temperature. 
After three washes for 10 min in TBST, the membrane was incubated for 
1 hour at room temperature with diluted (1:10000) anti-mouse HRP 
secondary antibody (A9044, Sigma). After another three washes of 
TBST, image was made by using ECL Plus Western Blotting Substrate 
(Pierce). The membrane was then stripped in 7 M Guanidine 
hydrochloride (Sigma), after two washes in TBST, the membrane was 
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subjected to anti-mouse GFP primary antibody (1:5000, ab1218, Abcam) 
and anti-mouse HRP secondary antibody (1:10000, A9044, Sigma) for a 
secondary round of analysis. 
2.7 Microscopy 
Microscopy was done as described (Xu et al., 2009). Briefly, Cells 
were observed and photographed on Zeiss Axiovert2 invert microscope 
and Axiovert200 upright microscope equipped with a Zeiss AxioCam 
MRc digital camera and AxioVision 4 software, and embryos and fry 
were visualized using a Leica MZFLIII stereo microscope (Leica) 
equipped with a Fluo III UV-light system and photographed by using a 
Nikon E4500 digital camera (Nikon Corp). 
2.8 Statistical analysis 
GRAPHPAD PRISM (version 6, La Jolla, CA, USA) software was used. 
To compare means, we used the unpaired T-test analysis. Statistical 
difference was considered significant and very significant if it had a two-
sided P-value of <0.05 and <0.01. 
2.9 Transcriptome sequencing 
Transcriptome sequencing was carried out on Hiseq 2000 platform 
from illumina. Pools of RNA were prepared, containing RNA extracted 
from eye, testes and ovary from adult fish, stage 10 embryos and young 
fries of 7dpf. Checked RNA (for integrity, purity and concentration as 
described before) was sent to the service provider BGI TECH 
SOLUTIONS (HONGKONG) CO., LIMITED (Hong Kong, China) for 
library preparation and the subsequent sequencing. During the QC steps, 
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ABI StepOnePlus Real-Time PCR System(ABI) were used in 
quantification and qualification of the sample library. 2x100 bp paired-
end reads were generated in a single lane from an Illumina HiSeq2000 
following the service provider’s protocol.  
2.10 Bioinformatics analysis of RNA-Seq 
After sequencing, 2x100 bp paired-end reads were generated, which 
were called raw reads. To illustrate the biological meaning of these 
sequences, the sequenced reads were first mapped to the medaka 
genome in order to get the region that were aligned, showing the origin 
of these sequences. Alignments would then be assembled to generate 
transcripts of genes. After that, transcripts of different sample libraries 
would be merged into a final transcriptome assembly. Further application 
of the trancriptome assembly includes annotation of the trancripts, 
counting of the reads so that the expression level of a particular 
transcript can be measured. All applications were applied on a 64-bit 
Ubuntu operating system (version 14.04, Canonical Ltd) 
2.10.1 Quality assessment and filter of raw reads 
Quality assessment of raw reads was performed by FastQC software 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) in its 
command line version, simply running the fastqc command with default 
options. 
2.10.2 Alignment/Mapping reads to genome 
For the alignment of reads to the genome, Tophat2 (version 2.0.13, 
http://ccb.jhu.edu/software/tophat/) was chosen as the reads mapper. 
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Medaka genome sequence (fasta format) and gene annotation (gtf 
format) was downloaded from Ensembl ftp site (version 77) as reference. 
To reduce the mapping of remaining rRNA, tRNA, non-coding RNAs 
were masked in the annotation file. The maximum intron length was set 
to 300000 for medaka. 
2.10.3 Quality assessment of alignments 
For quality assessment of alignments, Qualimap 
(http://qualimap.bioinfo.cipf.es/) was used in its command line version 
using the alignment files sorted  and masked gene annotation file 
2.10.4 Assembly of transcripts 
To assemble transcripts, Cufflinks (version 2.2.0, http://cole-trapnell-
lab.github.io/cufflinks/cufflinks/) was chosen as the genome-guided 
transcriptome assembler. Transcript assembly was carried out using 
masked gene annotation file to guide RABT assembly. 
2.10.5 Generation of transcriptome assembly 
To assemble transcriptome genearateed from each sample library, 
Cuffmerge (http://cole-trapnell-lab.github.io/cufflinks/cuffmerge/) was 
used to perform the merging of these assemblies into a master 
transcriptome for downstream differential expression analysis of the new 
transcripts that had been assembled.  
2.10.6 Counting the transcripts 
To measure the expression level of transcripts, Htseq-count was used 
to count the transcripts that come from the final transcriptome assembly.  
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2.10.7 Annotation of transcripts 
For annotation of transcripts in the final transcriptome assembly, 
BLAST+ suite from NCBI 
(ftp://ftp.ncbi.nlm.nih.gov/blast/executables/LATEST) was used to blast 
the merged library against the NCBI nucleotide collection (Nt) database 
using BLASTN and NCBI non-redundant (Nr) and Swiss-Prot protein 
sequence database using BLASTX with default settings following 









Chapter 3: Results 
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3.1 Differential evolution of duplicated fish mitf genes 
3.1.1 Medaka Mitf1 and Mitf2 correspond to mammalian MitfA and 
MitfM 
The sequenced medaka genome has two annotated mitf genes called 




SORLG00000003123 ). We followed this annotated gene nomenclature. 
The sequence appears to be partial for mitf1 and complete for mitf2. A 
sequence comparison led to a putative full length of open reading frame 
(ORF) for mitf1. Cloning of PCR products using primers in arrow in cDNA 
library of embryos and sequencing led to the discovery of the full length 
cDNA sequences for mitf1 and mitf2, which predict proteins Mitf1 and 
Mitf2 of 512 and 406 amino acid residues, respectively (Figure 3.1). On 
a sequence alignment, both medaka Mitf proteins are highly similar to 
the known Mitf homologues from other fish species and human (Figure 
3.2). 
A single gene in birds and mammals produces multiple Mitf isoforms 
with distinct N-terminal sequences. Two major isoforms are MitfA and 
MitfM, which in human have 118 and 11 amino acids in the N-terminus, 
respectively. Together with a comparison in protein domain structure 
especially the first exon (Figure 3.2), the medaka Mitf1 corresponds to 
the human isoform MitfA, and the Mitf2 is equivalent to the human MitfM. 
Therefore, the two major fish Mitf proteins encoded by two distinct genes 
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resemble the two major Mitf isoforms encoded by a single gene in higher 
vertebrates. 
 
Figure 3.1 Nucleotide and deduced amino acid sequence of medaka 
mitf1 and mitf2.  
(A) mitf1. (B) mitf2. Start codon and stop codon are shown in bold. 
Broken and solid arrows depict sequences of primers for PCR analysis 
and cDNA cloning, respectively. Sequences are deposited in GenBank 
under accession numbers KC249979 (mitf1) and KC249980 (mitf2). 
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Figure 3.2. Mitf protein sequence alignment. Common species 
names, Mitf proteins or isoforms and percentage sequence similarity 
values compared to the medaka Mittf1 and Mitf2 are seen. The basic 
helix-loop-helix leucine zipper sequences are indicated. Also indicated 
are activation domain 1 (AD1) and 2 (AD2), MAPK and GSK3β.  For 







So far the fish mitf genes and their protein products have controversially 
been named in the literature. For example, fish genes whose protein 
products are similar to the mammalian MitfM isoform have been called 
mitfa in zebrafish, fugu and tetraodon or mitfm in Xiphophorus, whereas 
those whose protein products are similar to the mammalian MitfA isoform 
have been referred to as mitf1 or mitfb (Altschmied et al., 2002; 
Delfgaauw et al., 2003; Lister et al., 2001). All the five sequenced 
genomes of fish species, namely zebrafish, medaka, fugu, tetradon and 
stickleback, contain two separate mitf genes. The gene pairs are 
annotated as mitf1 and mitf2 in both medaka and stickleback, which 
were followed in this study. On the basis of sequence alignment (see 
below), fish Mitf1 is more similar to the mammalian MitfA, and fish Mitf2 
is equivalent of the mammalian MitfM, respectively. Hence, mitfa or 
mitfm genes previously described in other fish species are equivalents 
of the medaka mitf2 gene, and previous mitfb genes correspond to the 
medaka mitf1. In this regard, the annotated stickleback Mitf1 and Mitf2 
appears to be equivalents of medaka Mitf2 and Mitf1, respectively 
(Figure 3.3A). Designation of fish mitf genes as mitf1 and mitf2 will allows 
to similarly nomenclature fish Mitf isoforms, a salient feature of the mitf 
gene as has been demonstrated in mammals (Hou and Pavan, 2008; 
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Vance and Goding, 2004). 
 
Figure 3.3 Phylogenetic tree of Mitf proteins. (A) Phylogenetic tree by 
the NJ algorithm. (B) Phylogenetic tree by minimum evolution. The 
Drosophila Mitf serves as the out-group. Bootstrap values are given. 
Accession numbers follow organisms and original names of Mitf proteins. 
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By using an invertebrate Mitf protein from Drosophila (Hallsson et al., 
2004) as the out-group, phylogenetic trees were constructed on the 
basis of amino acid sequences. In the phylogenetic tree constructed by 
using the neighbor-joining algorithm on the DNAMAN package, all 
vertebrate Mitf proteins fall into two major clades. One clade consists of 
fish mitf2 proteins only, and the other comprises fish Mitf1 proteins and 
all mammalian Mitf proteins, as represented by the human MitfA and 
MitfM isoforms (Figure 3.3A). However, fish Mitf2 but not Mitf1 proteins 
may clustered with tetrapod counterparts on phylogenetic trees 
constructed by minimum evolution methods (Figure 3.3B). The inter-
species mitf1 sequence similarity is generally higher than intra-species 
comparisons between mitf protein pairs in the fish species, suggesting 
that fish mitf duplicates may have shared an ancient WGD event in the 
common ancestor. 
3.1.2 Medaka mitf1 and mitf2 differ in sequence divergence rate 
A total of ~40 fish mitf sequences available in public databases 
(http://www.ncbi.nlm.nih.gov; http://www.ensembl.org). This allowed us 
to compare the sequence divergence of Mitf duplicates in various fish 
species by using tetrapod Mitf proteins as a reference (Table 1). Seven 
Mitf pairs of representative species fall into two categories. The first 
include Xiphophorus, fugu, two cichlid species and zebrafish and 
exhibits an apparent difference of 6% in sequence divergence between 
Mitf1 and Mitf2: On average, the 5 Mitf1 proteins are 73.5% identical to 
the tetrapod Mitf proteins, whereas this value decreases to 67.6% for the 
5 Mitf2 proteins (Table 1). Medaka also belongs to this category but 
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represents an extreme. Notably, the medaka Mitf1 is 72.2% similar to 
the tetrapod reference. However, this value for the medaka Mitf2 sharply 
declines to 60.2%, leading to a difference of up to 12% between the 
medaka Mitf1 and Mitf2 (Table 1). The second category is represented 
by stickleback, in which Mitf1 and Mitf2 display 67.1~69.7% and 67.6~72% 
identity values to the tetrapod reference, respectively, and thus a similar 
rate of sequence divergence. Taken together, medaka Mitf1 exhibits a 
slower, and perhaps basal, evolutionary rate of change, whereas Mitf2 
shows a significant acceleration in divergence rate. 
 
Table 1. Percentage Mitf sequence identities between fishes and 
tetrapods. Protein sequence accession number see Figure 3.3. Number 
in parenthesis shows the number of AAs in CDS.  
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3.1.3 Medaka mitf1 and mitf2 genes are the products of WGD 
Comparisons of chromosome locations revealed clear syntenic 
relationships between the mitf-bearing regions of human chromosome 3 
and those of fish chromosome pairs, chromosomes 5 and 7 in medaka, 
and chromosomes 6 and 23 in zebrafish, respectively (Figure 3.4). 
These data strongly suggest that the presence of mitf gene pairs in 
diverse fish species is the consequence of WGD, which has been dated 
~450 million years ago (Amores et al., 1998; Meyer and Schartl, 1999; 
Postlethwait et al., 2000). The chromosome syntenic relationship also 
demonstrates that the medaka mitf1 and mitf2 are homologs of the 
human Mitf gene. 
 
Figure 3.4. Fish mitf1 and mitf2 are homologs of the human Mitf by 
chromosome synteny. Medaka and zebrafish are compared to human. 
Data are compiled from http://www.ensembl.org/index.html. Chr, 
chromosome; numerals in parentheses, chromosomal positions. 
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3.1.4 Medaka mitf1 and mitf2 differ in the expression level 
In mammals, a single mitf gene shows differential expression from 
alternative promoters and exons, and thereby producing multiple 
isoforms (Bharti et al., 2008; Hallsson et al., 2000; Hershey and Fisher, 
2005; Steingrimsson et al., 2004). We performed RT-PCR analysis to 
examine mitf expression (Figure 3.5A). In adult tissues, the transcripts 
of both genes were detected in all samples examined, including the 
ectodermal skin, brain and eye, mesodermal muscle, heart, kidney and 
spleen, endodermal liver and gut, and male and female gonads (testis 
and ovary). There was no apparent difference between mitf1 and mitf2 
in a ubiquitous adult expression pattern. However, the level of mitf2 
expression appeared to be substantially lower than mitf1. After 36 cycles 
of PCR, mitf1 was easily detectable (Figure 3.5A), whereas mitf2 was 
barely detectable (data not shown). mitf2 became detectable only after 
40 cycles (Figure 3.A). In developing embryos, the transcripts of mitf1 
and mitf2 were detected as early as 2-cell stage (Figure 3.5A), 
suggesting their maternal inheritance. The expression of mitf1 and mitf2 
occurs throughout embryogenesis. Notably, the RNA is clearly more 
abundant for mitf1 than for mitf2 also in developing embryos. Real-time 
RT-PCR analyses (Figure 3.5B) revealed that the mitf1 RNA was more 
abundant than mitf2 by 3 and 8 fold in the adult skin and eye, and 3 and 
2 fold at embryonic stages 16 and 25, respectively. However, at the 4-
cell stage, the mitf2 RNA was more abundant than mitf1 by 5 fold. Taken 
together, mitf1 and mitf2 show different levels of RNA expression in 
embryogenesis and adult tissues. 
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Figure 3.5. RNA expression of mitf1 and mitf2 in medaka. (A) RT-
PCR analysis in adult tissues and embryos. The number of PCR cycles 
is given in parenthesis for each gene. (B) Real-time PCR analysis. β-
actin was used as the control for data calibration. Data are means ± s.d 
(error bars) of five determinations. **, p ≤ 0.01. (C-E) Chromogenic ISH 
with antisense riboprobes on whole mount embryos at stage 29. 
Melanocytes (asterisks) in the body, yolk sac (sc) and RPE are positive 
for tyr and mitf1 but not mitf2. (F and G) Cross-section of the adult 
posterior trunk after two-color fluorescence ISH with mitf1 (F) and mitf2 
(G) antisense riboprobes. ms, muscle; nt, neural tube; sc, spinal cord; 
sk, skin; vt, vertebra. Scale bars, 100 µm. 
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3.1.5 Medaka mitf1 and mitf2 differ in embryonic melanocytic 
expression 
To study the expression patterns of the medaka mitf1 and mitf2 in 
more detail, we performed in situ hybridization (ISH) in developing 
embryos at stage 29 (3 days post fertilization; dpf) (Xu et al., 2009), when 
pigment cells from the neural crest are clearly visible on the body and 
yolk sac, and pigmented RPE is evident in the eye (Iwamatsu, 2004). To 
prevent black pigmentation in melanocytes, we treated embryos with 
phenylthiourea and used them for ISH. We made use of the tyr transcript 
as a melanocyte marker, which encodes tyrosinase, the key enzyme for 
melanin synthesis in maturing/mature melanocytes (Koga and Hori, 
1997), In stage-29 embryos, tyr–positive cells were found as individual 
cells on the embryonic body, yolk sac and in RPE (Figure 3.5C). We 
found that mitf1 exhibited a similar expression pattern (Figure 3.5D). 
However, mitf2 expression was barely detectable at this stage (Figure 
3.5E). Taken together, the medaka mitf1 resembles the mouse mitfm in 
predominant expression in the pigment lineage, whereas the medaka 
mitf2 did degenerate its expression in embryonic melanocytes. This 
suggests that medaka mitf1 but not mitf2 might be a major player for 
embryonic melanocytes at this critical stage. 
We then performed fluorescence ISH to examine the adult expression 
on cross-sections of the posterior trunk. Both genes exhibited a 
ubiquitous expression in a wide variety of tissues, including the skin, 
muscle, neural tube and vertebra (Figure 3.5F and G). We noticed that 
the mitf2 signal was relatively stronger than mitf1 in the spinal cord and 
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muscle. Hence, mitf1 and mitf2 show a generally overlapping expression 
pattern in adult tissues. 
3.1.6 Medaka Mitf2 possesses a reduced melanogenic activity 
Mitf controls pigmentation through two distinct aspects: One is to 
regulate melanocyte formation and the other is to activate the expression 
of enzymes (e.g. tyrosinase) involved in melanin synthesis 
(melanogenesis) in maturing/mature melanocytes. The observation that 
the medaka mitf2 exhibits an accelerated sequence divergence rate and 
a lower level of expression provoked us to examine whether this gene 
has maintained activity. To perform transfection experiments in medaka 
ES cell line MES1, which is capable of directed melanocyte 
differentiation following transfection by pXmitf that expresses the 
Xiphophorus mitfm (Bejar et al., 2003), we constructed several 
expression vectors (Figure 3.6A). pTYRluc contains the 3.3-kb medaka 
tyrosinase gene a promoter (TYR) ahead of the luciferase (Luc), and 
pOmitf2 constitutively expresses the medaka mitf2 cDNA. In 
undifferentiated MES1 cells, mitf expression is not detectable by RT-
PCR analysis (Yi et al., 2009), but can be activated by forced XmitfM 
expression (Bejar et al., 2003). Transfection with pTYRluc alone or 
together with pCVpf as a control led to a low reporter activity, which was 
6 times that of transfection with pTAluc that contains a TATA-box 
minimal promoter. When pOmitf2 was used for cotransfection with 
pTYRluc, a 6.5-fold increase in luciferase activity was observed (Figure 
3.6B), demonstrating that the medaka Mitf2 maintains melanogenic 
activity. However, when pXmitf was used for cotransfection, an increase 
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by up to 178 fold was obtained (Figure 3.6B). Therefore, the 
melanogenic activity of the medaka Mitf2 is reduced by 27 fold compared 
to the Xiphophorus Mitf2. We then examined the induction of 
endogenous tyr expression by ectopic mitf expression in MES1 cells. 
Upon transfection with pOmitf2 and pXmitf, the tyr RNA expression was 
increased by 38 and 355 fold, respectively (Figure 3.6C). Compared to 
the Xiphophorus Mitf2, the medaka Mitf2 displays a 9.3-fold reduction in 
its activity to induce the endogenous tyr expression. Taken together, the 
medaka mitf2 retains melanogenic activity that has considerably been 




Figure 3.6. Medaka Mitf2 has a reduced activity. MES1 cells were 
used for cotransfection and analyses. (A) Vectors. (B) Luciferase 
reporter assay. Each of reporter plasmids pGL3luc, pTAluc and pTYRluc 
in combination with pRLluc was cotransfected with effector plasmids 
pOmitf2 or pXmitf into MES1 cells, and Luc activity was determined at 
day 3 dpt. pRLluc was used as the internal control for calibration of 
different samples and transfection efficiencies. pGL3luc was used as the 
negative control, whose activity was considered as background. pTAluc 
was used as the standard for normalization, whose activity was defined 
as unit activity. Fold activity was obtained by compared to control 
cotransfection with pCVpf. Data are means ±s.d of three experiments 
with triplicates each. (C) Real-time RT-PCR analysis of induced 
endogenous tyr expression. Data are means ±s.d of five determinations 
each. (D) Melanocyte formation. Data are means ±s.d of triplicate 
determinations in 12-well plates. P values are given in (B-D). (E) 
Micrographs showing the number of melanocytes relative to the number 
of GFP-positive transgenic cells. 
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3.1.7 Medaka Mitf2 possesses a reduced melanocyte-inducing 
activity 
We then addressed whether the medaka Mitf2 possessed 
melanocyte-inducing activity, the original function of the prototype 
mouse MitfM. To this end, we took the advantage of an in vitro system 
for melanocyte induction again by using the medaka ES cell line MES1, 
in which Xmitf expression is sufficient to direct melanocyte differentiation 
(Bejar et al., 2003). When pOmitf2 was used for transfection, 25 
melanocytes were formed per well of a 12-well plate. This number 
increased to 1298 for pXmitf transfection (Figure 3.6D). This difference 
by 52 fold is not ascribed to variations in transfection efficiency, because 
many GFP-positive transgenic cells following pOmitf2 transfection did 
not become melanocytes, whereas the majority of GFP-positive cells 
following pXmitf transfection did (Figure 3.6E). Convincingly, the 
medaka Mitf2 possesses a reduced activity for melanocyte induction in 
vitro compared to the Xiphophorus counterpart. 
 In summary, the duplicated mitf genes in medaka adopt two 
distinct directions of evolution: While mitf1 displays conservation, mitf2 
shows significant degeneration in protein sequence, expression and 
activity. 
3.2 Complimentary approaches for investigation of AT and AS 
3.2.1 Rapid amplification of cDNA Ends (RACEs) 
To identify possible transcript variants, 5’-rapid amplification of cDNA 
end (5’-RACE) and 3’-rapid amplification of cDNA end (3’-RACE) was 
performed on both medaka mitf1 and mitf2.  
  51
For 5’-RACEs of mitf1, a total of 385 RACE clones from the cDNA 
libraries of adult eye (n = 101), testes (n =48), ovary (n =70), morula 
embryos (n = 50) , blastula embryos (n =41 ) and larvae (n = 65 ) were 
sequenced, leading to the identification of 5 major types of mitf1 variants. 
For 5’-RACEs of mitf2, a total of 221 RACE clones from the cDNA 
libraries of morula embryos (n = 27), blastula embryos (n = 65), larvae 
(n = 65) and adult eyes (n = 64) were sequenced. The mitf2 produced 3 
types of cDNA, one of which encodes Mitf2M, an equivalent of the 
mammalian MitfM. The other two were alternatively spliced. One skipped 
exon 5b, which is unique in fish but absent in mammals and the other 
skipped exon 8.They are named mitf2Δ5b and mitf2Δ8. This proves the 
existence of AS for mitf2. For 3’-RACEs of mitf1, a total of 62 clones from 
the cDNA library of blastula embryos (n = 23) and larvae (n =40) were 
sequenced, but only 2 types of cDNA were obtained. One was the 
original full length, one showed the skipping of exon 5b. This proves the 
existence of AS for mitf1. The results of RACE can be seen as a series 
of Bernoulli trials when we focus on the detection of a specific RNA 
variant. In this case, there is a formula to describe the binomial 
proportion confidence interval which is p ± 𝑧1−0.5𝛼√𝑝(1 − 𝑝)/𝑛 where p 
is estimated proportion of successes, 𝑧1−0.5𝛼 is the 1-0.5α percentile of 
a standard normal distribution,𝛼  is the error percentile and n is the 
sample size (Brown et al., 2001). At a 95% confidence level, α is 0.05 
and 𝑧1−0.5𝛼 is 1.96. At 90% confidence level, z is 1.64. In this way, a 
sample size of 40 is sufficient to identify an unknown mitf RNA variant 
that is presumed to be 10% of all variants at 95% confidence level. 
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Increasing total number of clones to 150 can even be able to detect a 
rare variant whose abundance is only 2% at 90% confidence level. The 
total RACE clone numbers fulfilled this last stringent requirement but for 
individual cDNA library, the clone number may not be sufficient for a 
stringent conclusion. This required the other approach to investigate AT 
and AS for mitf genes: RNA-Seq. 
3.2.2 RNA-Seq 
The other approach to identify possible transcript variants was RNA-
Seq. Similar to RACEs, cDNA libararies of adult eye, testes, ovary, 
blastula embryos and larvae was constructed and sequenced in the NGS 
platform. As shown in Table 2, for each sample, approximately 47 million 
2x100 bp paired-end reads were generated. A total of 235,395,146 reads 
were obtained. To illustrate the biological meaning of the raw reads, the 
sequenced reads were mapped to the medaka genome in order to get 
the region that were aligned, showing the origin of these sequences. 
Alignments would then be assembled to generate transcripts of genes. 
After that, transcripts of different sample libraries would be merged into 
a final transcriptome assembly. A total of 94,515 contigs were 
assembled from these reads with N50 of 3,673 bp. This final 
trancriptome assembly was used for annotation of the trancripts and 
29,535 unigenes were obtained after filtering. Annotation of these 
unigenes was carried out using BLASTX searches against the NCBI 
non-redundant (Nr) protein sequence database. 23,123 (78.28%) of 
unigenes shared significant similarities with the matched protein 
sequences with the threshold of  E ≤1e-15. This number is larger than 
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gene number in public database from Ensembl (19,699 coding genes) , 
published transcriptome analysis in other studies (Lai et al., 2015) and 
databases in the PhyloFish project (Accession: PRJNA255889) 
suggesting the good quality of the assembly.  
 
Table 2. Summary statistics of the RNA sequencing. 
 
Unlike RACE, the problem of test number was easily overcome due 
to large number of reads generated by the powerful sequencing platform. 
With the help of RNA-Seq, situations of exon skipping and alternative 
promoter usage can be directly seen by exon distributions and alignment 
of reads in the iGV viewer, which discovers AT and AS variants easily 
(Figure 3.7). For example, a skipping of exon 5b was observed in both 
mitf1 and mitf2 and an alternative promoter usage was found in mitf1 
while it was not annotated in the known annotation file. In the final 
transcriptome assembly, a total of 11 variants of mitf duplicated genes 
were found, 8 for mitf1 and 3 for mitf2. As shown in Figure 3.8, mitf1 has 
both AT and AS while mitf2 only has AS. The relatively large ‘test’ 
numbers seemed to explain why RNA-Seq revealed more AS variants 
of mitf1 than RACEs. Detailed description of these AT and AS will be 
discussed separately in the following chapters. 
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Figure 3.7 RNA-Seq discovers AT and AS variants.  
With the help of RNA-Seq, situations of (A) Exon skipping and (B) 
Alternative promoter usage can be directly seen by exon distributions 
and alignment of reads in the iGV viewer, which discovers AT and AS 
variants easily. Junctions of the reads are marked as blue lines linking 
the exons (grey boxes). 
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Figure 3.8. Medaka mitf transcripts revealed by RNA-Seq. By 
applying RNA-Seq, in total, 11 variants of mitf genes were found. mitf1 
has both AT and AS (A) while mitf2 only has AS (B). 
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Since counts of the reads can be measured for a particular transcript, 
the expression level of a particular transcript or a gene can be assessed. 
For example, Morula embryos and ovary had a similar expression level 
of mitf genes, for both mitf1 and mitf2 (Figure 3.9). mitf2 was expressed 
dramatically lower than mitf1 in each organs or development stages 
examined. This trend is consistent with the results in Figure 3.5 A and B. 
For mitf1 expression, it was lower in early embryonic stages than in the 
adult organs. For mitf2, it was the opposite. However, RNA-Seq has the 
inevitable problem of false positive and false negative results which 
cannot be purely eliminated. For example, if we look for a closer 
examination of a specific mitf AT and AS variant, FPKM value was 
sometimes too small (lower than 0.1) and SE could be large (data not 
shown), which reduced the reliability of this digital expression and 
increased the necessity of further validation of AT and AS variants by 
PCR and cloning. Actually, this problem was to some extent already 
solved in the former RACEs experiments and only a small fraction of 
variants validation was needed. 
In summary, the combination of RACE and RNA-Seq help to reveal 
the mitf AT and AS variants to a largest extent. 
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Figure 3.9. Relative expression of mitf genes in the RNA-Seq 




3.3 Alternative transcription of duplicated fish mitf genes 
3.3.1 Medaka mitf1 produces multiple AT isoforms 
As already shown in the above chapters, after applying 5’-RACE and 
RNA-Seq, 5 AT variants were found. According to the predicted protein 
sequences (Figure 3.10A), the 4 out of these 5 mitf1 variants were found 
to encode Mitf1A, Mitf1B, Mitf1H and Mitf1M, equivalents of their 
mammalian isoforms MitfA, MitfB, MitfH and MitfM, which in human have 
118, 83, 20 and 11 amino acid residues in the N-terminus, respectively. 
The remaining mitf1 variant had a first exon of 81 bp, but the first exon 
did not include transcription start site. This first exon has no equivalent 
in mammals and other vertebrates (Figure 3.11A). Thus, this variant was 
named mitf1n due to the discovery of the novel first exon/promoter. For 
mitf2, 5’RACE and RNA-Seq revealed that the mitf2 ulitize the same first 
exon. The complete cDNA encodes Mitf2M, an equivalent of the 
mammalian MitfM. Therefore, the mitf1, but not mitf2, has 
evolved/retained the ability to utilize alternative promoter/first exons to 
produce isoforms as in mammals. 
 A comparison between cDNAs and genomic sequences revealed 
a conserved gene structure between both fish mitf genes and human 
gene, with the 4 alternative promoters being similarly positioned in fish 
and human, with 1n promoter residing between 1b and 1m promoter 
(Figure 3.10B). A closer examination identified conserved positioning 
and organization of alternative exon 1a, 1h, 1b and 1m of gene mitf1 as 
well as the mitf2 first exon 1m  between fish and human (Figure 3.11B-
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F). Taken together, the mitf1, but not mitf2, shows a highly conserved 
mechanism of alternative transcription. 
 
Figure 3.10. Structure and RNA expression of medaka Mitf1 and 
Mitf2. (A) N-terminal sequences of medaka Mitf proteins and isoforms. 
Amino acid sequences of alternative exon 1 are highlighted in color. (B) 
Genomic organization highlighting alternative exon 1. Numbering of 
exons (boxes) and sizes of introns (thin lines) are given. Fish genes have 
lost the human exon 3 but acquired exon 5b. Arrowheads define primers 
used for RT-PCR analysis. (C and D) RT-PCR analysis in adult organs 




Figure 3.11. Alternative first exons. (A) First exons are highlighted in 
the genomic organization and the length is labeled. They are named 
after the similarity of human MITF gene. Black box indicates ORF. (B-F) 
Exons are shown in capital letter together with single-letter amino acid 
sequences, introns are in small-case letter. (B) Exon 1a. (C) Exon 1h. 
(D) Exon 1b. (E) Exon 1n. This novel exon has no equivalent in 
mammals and other vertebrates and does no encode amino acids. (F) 
Exon 1m. The exon is shown together with its junction intronic sequence 
and encoded 11 amino acids. 
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3.3.2 Expression of mitf1 and mitf2 AT variants 
After identification of mitf1 AT variants, we were interested in the 
expression patterns of them. As illustrated in Figure 1B, several 
combinations of primers were used to detect all the 5 mitf1 AT variants 
(common primers spanning exon 2 to exon 5) and specific variants (a 
specific primer unique to one of the alternative first exons plus a primer 
in exon 5) by RT-PCR analyses. By using the common primers, the mitf1 
and mitf2 RNAs were found to be present in all adult organs examined 
and throughout embryogenesis (Figure 3.10C and D). PCR with specific 
primers revealed differential expression of mitf1 AT variants. Among the 
adult organs examined, mitf1a and mitf1b exhibited wide distribution and 
were most abundant in the liver, gut and testes. However, mitf1a had a 
relatively higher expression in the eye while mitf1b was expressed higher 
in the heart. mitf1h was limited to the eye, heart, liver and testes, 
whereas mitf1m was easily detectable  in the skin and eye (Figure 
3.10C). For mitf1n was found to be expressed in skin, brain, eye and 
gonads. Furthermore, these primers were further applied to droplet 
digital PCR (ddPCR) to obtain a more accurate and quantitative result. 
Differential RNA abundance in adult organs became more evident upon 
ddPCR analyses (Figure 3.12). This validated the RT-PCR results. 
Differential expression was seen also seen in medaka embryogenesis. 
For instance, mitf1b and mitf2 RNAs are present already at the 4-cell 
stage and persists throughout subsequent stages of development until 
hatching, indicating that they are maternally supplied. The mitf1 RNA 
variants mitf1a, mitf1h and mitf1m are not detectable until the late 
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gastrulation onwards (Figure 3.10D), suggesting that they are not 
maternally provided. Taken together, AT variants encoding the 5 Mitf1 
























































Figure 3.12. ddPCR analysis of mitf1 AT variants. Each variant was 
colored according to Figure 3.10B. Values are copy numbers per µl 
normalized to β-actin. 
 
3.3.3 Activities of Mitf isoforms on target genes’ promoters 
To determine the relative activities of Mitf isoforms as effectors for 
reporter assays, a total of 6 constructs were made, which express Mitf2M, 
Mitf1A, Mitf1B, Mitf1H, Mitf1M, and Mitf1N, with the last being the 
expression of mitf1n which does no encode amino acids in its first exon 
(Figure 3.13A). The primary function of Mitf is to activate or upregulate 
the expression of genes involved in pigment cell differentiation/survival 
and melanin synthesis. One of the best studied Mitf target genes is tyr 
(Li et al., 2013b), which encodes tyrosinase essential for catalyzing the 
melanin synthesis from tyrosine.  Recently, Mitf has been found to be a 
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transcriptional activator of germline genes dazl, dnd and vasa (Zhao et 
al., 2012). Therefore, TYR and DAZ, the promoters of medaka tyr and 
dazl genes, were linked to luc, resulting in pTYRluc and pDAZluc, were 
used as two separate reporter systems (Figure 3.13B). For reporter 
assays, either pTYRluc or pDAZluc was co-transfected with one of the 
effector plasmids into MES1 cells, and luciferase activity was determined 
at 3~4 days post transfection (dpt). 
Upon cotransfection with pTYRluc, different Mitf proteins and isoforms 
exhibited considerably varying activities (Figure 3.13C). Specifically, 
Mtif1B displayed the strongest activity, Mitf1M and Mitf2M exhibited 
moderate activity, whereas Mitf1A and Mitf1H had little enhancing 
activity. Interestingly, Mitf1N was comparable to Mitf1M in activity, 
demonstrating that deletion of the N-terminus does not affect the 
Mitf1M’s activity on pTYRluc. Upon cotransfection with pDAZluc, Mitf1A, 
Mitf1B, MitfH and Mitf2M enhanced the activity by 2.5~3.8 fold, whereas 
Mitf1M and Mitf1N were inefficient in enhancing the activity (Figure 
3.13C). Taken together, different Mitf1 isoforms and Mitf2M show 
dramatic differences in transcriptional activity on the TYR and DAZ 
promoters, and different N-terminal sequences largely determine the 
target-specific activity. One obvious exception to this is the difference in 
activity between Mitf1M and Mitf2M on the DAZ promoter, which may be 
due to considerable amino acid sequence divergence (61% identity) 
between the two proteins (Table 1) (Li et al., 2013a) (Li et al., 2013b). 
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Figure 3.13. Relative activities of isoforms of Mitf1 and Mitf2. (A) 
Effector and selection vectors. CV, the human cytomegalovirus 
immediate early enhancer/promoter; Omitf1a, b, h, m and n, cDNAs 
encoding the medaka isoforms Mitf1A, B, H ,M and N; Omitf2, cDNA 
encoding the medaka Mitf2M; pf, cDNA encoding the fusion PF between 
puromycin acetyltransferse and green fluorescent protein. (B) Reporter 
vectors. DAZ, medaka dazl promoter; TA, minimal promoter containing 
a TATA-box; TYR, medaka tyrosinase promoter; luc, firefly luciferase; 
Rluc, renilla luciferase as the internal control; pGL3-basic, promoterless 
vector as the negative control. (C) Reporter assays by cotransfection in 
the medaka ES cell line MES1. The reading from pGL3-basic was 
defined as the background. The reading from pTAluc transfection was 
used for normalization. The reading from cotransfection with pCVpf as 
the control was defined as unit activity for comparison. Relative activities 
are means ± s.d. (bars above columns) from three independent 
experiments of transfection in triplicate each. **, very significant 




Figure 3.14. Induction of melanocyte differentiation and tyr RNA 
expression by Mitf proteins.  (A) Melanocytes induced by Mitf1B, 
Mitf1M and Mitf2M. Melanocytes are visible as relatively large and 
flattened cells (asterisks) that are dendritic and rich in melanin granules 
(black). GFP expression from co-transfected pCVpf served a control for 
similar transfection efficiencies between experiments. (B) Different 
activities on melanocyte induction. (C) Effect on tyr RNA expression by 
real time RT-PCR 4 days after gene transfection. Data are means ± s.d 
(bars above columns) from three independent experiments in triplicate 
each. Scale bars, 10 µm.  
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3.3.4 Induction of melanocytes and tyr RNA expression in ES cells 
Previously, we and others have shown that mammalian and 
Xiphophorus MitfM is sufficient to induce melanocyte formation in mouse 
fibroblasts (Tachibana et al., 1996), avian neuroretina cells (Planque et 
al., 1999), medaka ES cells (Bejar et al., 2003) and male germ stem cells 
(Thoma et al., 2011). The medaka Mitf2M is also capable of melanocyte 
induction in medaka ES cells (Figure 3.6). This time, further 
determination of whether Mitf isoforms other than MitfM also possessed 
this ability was carried out. For this, each of the 6 Mitf-expressing 
plasmids was introduced together with pCVpf into MES1 cells, and the 
cells at 7 dpt were observed for melanocyte formation by microscopy 
(Figure 3.14A and B) and for tyr RNA expression induction by real-time 
PCR (Figure 3.14C). It was found that not only Mitf1M and Mitf2M but 
also Mitf1B were capable of melanocyte induction, whereas Mitf1A, 
Mitf1H and Mitf1N were not (Figure 3.14A and B). Quantitatively, Mitf1M 
was the strongest of the three Mitf proteins, which induced 22 
melanocytes per well, Mitf2M was moderate and produced 10 
melanocytes per well, whereas Mitf1B was the weakest and produced 
only 6 melanocytes per well (Figure 3.14B). We compared the relative 
activities of the 3 melanocyte-inducing Mitf proteins on inducing tyr RNA 
expression. Mitf11M and Mitf2M produced 39- and 38-fold induction, 
whereas Mitf1B exhibited 64-fold induction. Collectively, Mitf isoforms 
show dramatic differences in the ability and efficiency in the induction of 
melanocyte differentiation and endogenous tyr RNA expression, and the 
N-terminus of the isoform Mitf1M is essential for melanocyte-inducing 
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activity. Furthermore, these data also provide first evidence that the 
melanocyte-inducing activity of a Mitf protein is associated with but not 
identical to the melanogenic gene-regulating activity. 
3.3.5 Activities of Mitf isoforms on the expression of cell lineage 
markers 
Differential expression and activities provoked us to determine the 
effect of Mitf1 isoforms as well as Mitf2M and XmitfM on inducing the 
expression of marker genes of diverse cell lineages (Figure 3.15). The 
pigmentary lineage comprises solely melanocytes in mammals but 4 
distinct pigment cells, namely melanophores, iridophores, xanthophores 
and leucophores (Kelsh et al., 2004). Upon forced expression, XmitfM, 
Mitf2M and Mitf1 isoforms - including Mitf1N but except Mitf1H - were 
capable of inducing to varying extent the RNA expression of tyr and 
xanthine dehydrogenase (xdh), the later being a putative marker of 
xanthophores (Ben et al., 2003). Only Mitf1M remarkably activated tyrp1, 
a gene involved in melanogenesis, whereas Mitf1N exhibited a reduced 
activity. All the Mitf proteins was able to induce cart1, nkx2.5 and p53, 
the markers for cartilages (Zhao et al., 1993), cardiomyocytes (Lyons et 
al., 1995) and general ES cell differentiation (Bejar et al., 2003), but none 
of them activated pax3a, pax6a and hnf3b, the medaka homologs of 
markers for neural crest, neuroectoderm and endoderm (Hong et al., 
2012; Li et al., 2009). Notably, Mitf1H exhibited the highest activity to 
preferentially induce actn2 and myhl1, markers for cardiomyocytes and 
muscles. Interestingly, Mitf1A, Mitf1B, Mitf1H and XmitfM were able to 
upregulate germline genes dazl and vasa, whereas Mitf1M, Mitf1N and 
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Mitf2M were not. Taken together, Mitf isoforms show clear differences in 
activity, specificity and efficiency for regulating gene expression in the 
pigmentary lineage and others, and the N-terminus plays an essential 
role in determining the activity and specificity of Mitf isoforms. 
 
Figure 3.15. Mitf isoforms have different activities on lineage gene 
expression. The ES cell line MES1 in 12-well plates was transfected 
with pCVpf alone (control) or together with vectors expressing different 
Mitf proteins and medaka Mitf1 isoforms, grown in the presence of 1 
ug/ml puromycin to enrich for transgenic cells and analyzed at day 4 post 
transfection for gene expression by RT-PCR. RT-PCR was run in a 20-
µl volume containing 40 ng of cDNA for 40 cycles and the reaction was 
separated on 1% agarose gels. Germ layers or cell types and genes are 
shown to the left, sizes of PCR products to the right. Differentially 
expressed genes are shown in bold.  
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3.3.6 Expression and stability of Mitf protein isoforms 
The fact that Mitf1 isoforms and Mitf2M upon forced expression exhibit 
apparent differences in regulating the expression of reporter genes and 
endogenous genes provoked us to examine whether this were due to 
differential expression and/or activity of protein isoforms. To this end, we 
made a series of six constructs that express the 5 Mitf1 isoforms and 
Mitf2M as a fusion with mCherry and examined the level of protein 
expression in vitro and in vivo. In vitro, the medaka ES cell line MES1 
was used again for transfection with each of the constructs and analyzed 
by fluorescent microscopy at 2 dpt. As illustrated in Figure 3.16A, the 6 
constructs produced a similar efficiency of cells that expressed mCherry. 
This suggests that the constructs are not different from each other in the 
level of tagged protein expression, and that the Mitf1 isoforms and 
Mitf2M appear to have similar stability in medaka ES cells. In vivo, 
medaka embryos at the 1-cell stage were microinjected with each of the 
constructs and analyzed at 2 dpf when they reached the gastrula stage 
(Figure 3.16B). Fluorescent microscopy revealed that the 6 constructs 
gave rise to a similarly high level of expression of Mitf1 isoforms and 
Mitf2M in fusion with mCherry (Figure 3.16C), as compared to GFP 
expression from coninjected plasmid pCVpf as the internal control 
(Figure 3.16D). Furthermore, microinjected embryos were pooled at the 
gastrula stage and subjected to Western blot analysis by using 
monoclonal antibodies against mCherry and GFP. This revealed a 
similar level of protein amount for each of the Mitf1 isoforms and Mitf2 
when calibrated with the GFP signal from coinjected pCVpf (Figure 3.17). 
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Therefore, both in vivo during embryogenesis and in vitro in cell culture, 
Mitf1 isoforms and Mitf2M do not differ from each other in expression 
and/or stability, and differences in activity are largely due to different N-
terminal sequences encoded by alternative exon 1 as well as sequence 
divergence between Mitf1M and Mitf2M. 
In summary, one of the duplicated medaka mitf genes, mitf1 is capable 
of producing multiple RNA variants by alternative transcription, and Mitf 
isoforms show differential expression and significantly varying activities 
and efficiencies in regulating the expression of genes important for 
pigment cells, germ cells and other cell lineages. 
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Figure 3.16. Expression and stability of Cherry-tagged Mitf 
isoforms. (A) Micrographs showing expression of Mitf isoforms in vitro. 
MES1 cells were transfected with each of plasmids for mCherry-tagged 
Mitf isoforms plus pCVpf at a 1:4 ratio and were photographed at day 2 
post transfection. (B-D) Micrographs showing expression of Mitf 
isoforms in vivo. Embryos at the 1-cell stage were injected with each of 
plasmids for mCherry-tagged Mitf isoforms plus pCVpf at a 1:1 ratio (total 
25 pg/nl) and analyzed at day 2 post fertilization (the mid-gastrula stage). 
(B) Bight field. (C) mCherry. (D) GFP. Scale bars, 50 µm in (A) and 500 




Figure 3.17. Expression and stability of mCherry-tagged Mitf 
isoforms. (A) Embryos at the 1-cell stage were injected with each of 
plasmids for mCherry-tagged Mitf isoforms plus pCVpf at a 1:1 ratio (total 
25 pg/nl) and analyzed at day 2 post fertilization (the mid-gastrula stage) 
to perform western blot with anti-mCherry and GFP antibody 
respectively. (B) Mitf isoform expression was quantified by mCherry level 
after normalization to GFP level. Bars indicate fold expression of 
mCherry vs GFP. The relative expression of mCherry in Mitf1A is 
arbitrarily defined as unit expression (black). 
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3.4 Alternative splicing of duplicated fish mitf genes 
Both RNA-Seq and RACEs results proved the existence of AS in 
duplicate mitf genes. RNA-Seq revealed that the mitf1 produced 3 types 
of AS variants (Figure 3.18A), one skipped the exon 5b in mitf1b and the 
other 2 had an alternative 3’-splice site in exon 6 which lead to a deletion 
of a Glutamic acid at position 288 (Mitf1a as standard) for mitf1a and 
mitf1m. In this way, the AS variants of mitf1 were named mitf1bΔ5b and 
mitf1aΔE288 and mitf1mΔE288. Since RACEs failed to discover the 
mitf1ΔE288 and there is also possibilities of false discovery in RNA-Seq, 
further validation was carried out. The first step was to validate the 
existence of these 2 types of AS. Specific primers that could recognize 
the skipping of exon 5b and deletion of E288 were designed. In ddPCR, 
the mitf1 AS variants were successfully found in adult organs but 
compared to mitf1 AT variants, the expression level was quite low 
(Figure 3.19A). The second step was to further validate the specific AS 
variant. According to the above result, skin, eye, testes and ovary was 
chosen for RT-PCR. Primers that can distinguish specific variants were 
used. As shown in figure 3.20, mitf1b∆5b is clearly seen in the eye but 
absent in the skin, testis and ovary.  
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Figure 3.18. Alternative splicing of mitf genes in medaka. The 
length of exon 5-9 are labeled Black box indicates ORF. (A) mitf1. 
Three forms of alternative splicing are found. One skipped the exon 5b 
and the other two had an alternative splice acceptor in exon 6 which 
led to a deletion of a Glutamic acid. (B) mitf2. Two forms of AS were 
found. One skipped the exon 5b and the other skipped exon 8. 
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Figure 3.19. Differential expression of mitf AS variants.  
Relative expression of mitf1 (A) and mitf2 (B) AS variants are shown. 
Values are copy numbers per µl normalized to β-actin 
 
Figure 3.20 Validation of mitf AS variants. The RNA of variant 
mitf1b∆5b is clearly seen in the eye but absent in the skin, testis and 
ovary. 
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Consistent with RACEs results, RNA-Seq revealed that the mitf2 
produced 3 types of cDNA, one of which encodes Mitf2M, an equivalent 
of the mammalian MitfM(Figure 3.18B). The other two were alternatively 
spliced. One skipped exon 5b (similar to mitf1) the other skipped exon 8. 
They are named mitf2Δ5b and mitf2Δ8. To verify the expression patterns 
of mitf2 variants to a more complete extent, ddPCR was carried out 
(Figure 3.19B). Primers that can distinguish mitf2 AS variants were used. 
The results showed differential expression of these variants in different 
organs. mitf2m exhibited wide distribution while mitf2Δ5b showed 
expression limited in skin, brain, eye and ovary, and mitf2Δ8 was 












Chapter 4: Discussion 
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4.1 Gene duplication and differential evolution 
The role of gene duplication in evolution is perhaps best illustrated by 
the growth hormone (GH)-prolactin (PRL) family (Forsyth and Wallis, 
2002). This family consists of GH, PRL, somatolactin (SL) and placental 
lactogen (PL), which has arisen from a single ancestor by gene 
duplication followed by extensive functional divergence. Although GH 
retains the original role in growth control in all vertebrate species, the 
other members have distinctive functions between fish and mammals: 
PRL is important for the mammary gland in mammals but for 
osmoregulation in fish (Sakamoto and McCormick, 2006), SL is fish-
specific and selectively regulates proliferation and morphogenesis of 
pigment cells (Fukamachi et al., 2004), and PL is specific to mammals 
and essential for placental development. They also exhibit differences in 
expression pattern: GH, PRL and SL retain the pituitary expression, 
whereas PL expression occurs in the placenta. 
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Figure 4.1. Different models of duplicate gene evolution. A WGD 
event results in the formation of two identical duplicates of every gene. 
Duplicate genes can undergo different models of evolution that leads to 
functional divergence. In DDC model, duplicated genes undergo partial 
and complementary degenerative mutations to perform complementary 
functions that jointly match the function of a single ancestral gene. This 
would lead to subfunctionalization. In DCD model, one of the 
duplicated genes retain the original expression and function, and other 
undergoes degeneration in expression and/or sequence to acquire an 
emerging new function or total loss of its original function. In this way, 
nonfunctionalization or neofunctionalization would take place.  
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Fish models provide an ideal system to study the models and 
mechanisms of duplicated genes’ evolution in vertebrates. After split 
from the tetrapod lineage, fish has undergone a third WGD event in the 
common ancestor of all modern-day teleosts (Amores et al., 1998). 
Interestingly, the resultant genome-wide gene duplicates usually coexist, 
leading to more genes in fish (Meyer and Schartl, 1999). As shown in 
Figure 4.1, the duplication-degeneration-complementation (DDC) model 
was originally proposed in zebrafish to explain the preservation of 
duplicated genes: Duplicated genes undergo partial and complementary 
retention and degeneration to perform complementary functions that 
jointly match the function of a single ancestral gene (Force et al., 1999). 
This DDC model emphasizes that complementary mutations in the 
regulatory sequences of gene duplicates lead to the retention rather than 
the loss of gene duplicates following WGD (Force et al., 1999).  
Neofunctionalization has recently been reported for the evolution of 
an antifreeze protein under escape from adaptive conflict in an antarctic 
zoarcid fish (Deng et al., 2010). In the case of neofunctionalization and 
nonfunctionalization, one of the duplicated genes must retain the original 
expression and function, and other undergoes degeneration in 
expression and/or sequence to acquire an emerging new function or total 
loss of function. Therefore, the duplication-conservation-degeneration 
(DCD) may represent a transitory status from gene redundancy to 
nonfunctionalization or neofunctionalization. The DCD model is elusive 
to study, because it is often difficult to determine whether a gene under 
degeneration is indeed a degenerating gene: its remnant expression 
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and/or activity could obscure observation and experimentation. 
Consequently, compelling evidence for the DCD model has been absent, 
and the mechanism underlying this model has remained poorly 
understood. 
4.2 Differential evolution of mitf genes 
We have recently identified Mitf as a transcriptional activator of 
medaka germline genes in vitro (Zhao et al., 2012), and both mitf1 and 
mitf2 mRNAs as the component of the Balbiani body (Li et al., 2013a), a 
structure resembling germ plasm  that exist transient in growing oocytes 
(Xu et al., 2010). In charpter 3.1, we have identified the medaka mitf1 
and mitf2 gene duplicate as the homologs of the mouse mitf. Strikingly, 
the medaka mitf1 retains expression in the embryonic pigmentary 
lineage including both melanocytes and RPE, in which the medaka mitf2 
lacks detectable expression. We are suggesting that medaka fits the 
DCD model for the evolution of duplicated mitf genes: In the developing 
embryo, mitf1 has retained the original melanocytic expression and 
perform the ancestral mitf function, whereas mitf2 has undergone 
degeneration to such a degree that its melanocytic expression becomes 
hardly detectable at the critical stages. In contrast, zebrafish utilizes the 
DDC model for the evolution of its duplicated mitf genes, where both 
genes have undergone partial retention and degeneration to jointly 
display complementary expression and thus execute complementary 
subfunctions of a single ancestral mitf in both melanocytes and RPE. 
Whether mitf2 degeneration is towards neofunctionalization or 
nonfunctionalization remains open. 
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Concurrent retention and loss of expression in the embryonic 
pigmentary lineage is a key feature of the DCD model. Since various cell 
lineages are formed during embryogenesis, loss of expression at critical 
stages of embryogenesis may exclude an essential role for the 
degenerating mitf2 in the pigment lineage establishment. Notably, the 
mitf2 (also named mitfa) promoter can drive transgene expression in 
adult pigment cells (Schartl et al., 2010). 
Besides the loss of expression in the embryonic pigmentary lineage, 
the medaka mitf2 also shows an expression level that is much lower than 
the conserved mitf1 in both embryos and adult tissues. We show that 
reduced mitf2 expression is not compensated by increased melanocyte-
inducing and melanogenic activity, but instead, accompanied by a 
remarkably degenerated melanogenic activity. These facts together with 
a higher divergence rate of the Mitf2 sequence strongly suggest that 
mitf2 has already been released from the constraint for pigment 
development and is in a transitory status towards neofunctionalization or 
nonfunctionalization. The mouse mitf is also expressed in several non-
pigmentary lineages in the form of various variants. A substantially lower 
expression level would imply that mitf2 has degenerated its role to some 
extent also in non-pigmentary lineages. It deserves to note that in the 
case of medaka mitf gene pair, the DCD model operates at multiple 
aspects, including sequence divergence rate, expression and activity of 
the protein product. It is unknown whether these aspects act 
independently or collectively.  
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Expression of the Xiphophorus mitf gene pair has been examined by 
RT-PCR analysis in adult tissues: mitfb shows ubiquitous expression, 
whereas mitfm is expressed only in the eye, skin and melanomas 
(Altschmied et al., 2002). This suggests that the Xiphophorus mitf 
duplicate also adopt the DCD model: mitfm has retained its pigmentary 
expression, whereas mitfb has acquired non-pigmentary expression in 
the adulthood. It is unknown whether the mitf genes also use the DCD 
model during Xiphophorus embryogenesis. 
To compare the relative protein activity, we have chosen the medaka 
Mitf2 and its Xiphophorus counterpart Xmitf, the latter being the only fish 
Mitf that has been studied both for expression in vivo (Delfgaauw et al., 
2003) and activity in vitro (Bejar et al., 2003). This comparison has 
revealed a great reduction in the activity of the medaka mitf2 protein 
product, consistent with its accelerated protein sequence divergence 
indicative of degeneration. Our finding that the wide adult expression of 
medaka mitf2 accompanies the retention of melanocyte-inducing activity 
by its protein product in combination with the fact that Mitf is a 
melanocyte master regulator raises an interesting question as to why 
many mitf2-expressing cells do not become melanocytes. A low level of 
expression and a dramatically reduced activity for melanocyte induction 
may account for an insufficient activity for melanocyte induction in non-
pigment cells. This notion is supported by the fact that the expression of 
highly active Xmitf is limited to the pigment cell-containing tissues in 
Xiphophorus (Altschmied et al., 2002). It deserves to note that the 
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medaka mitf2 has been compared for melanogenic activity and 
melanocyte induction with the Xmitf in this study.  
Our observation that both mitf1 and mitf2 are maternal factors in 
medaka is intriguing, because in all other vertebrate species examined 
so far, the mitf gene does not show maternal inheritance and its 
expression does not commence until late stages of embryogenesis when 
the pigment cell lineage starts to develop. For example, zygotic mitf 
expression occurs at the 16-somite stage in zebrafish (Lister et al., 2001; 
Lister et al., 1999), stage 21/22 in Xenopus (Kumasaka et al., 2004), the 
5-day-old embryo in chicken (Mochii et al., 1998) and the 9.5-day-old 
embryo in mouse (Nakayama et al., 1998). Interestingly, mitf maternal 
inheritance has been described in diverse invertebrate species such as 
Drosophila (Hallsson et al., 2004) and ascidians (Yajima et al., 2003).  
Our data illustrate that the mitf gene duplicate may adopt different 
ways of evolutionary divergence in different species. This species-
specific difference has recently reported also to tyrp1 encoding 
tyrosinase-related protein 1 (Tyrp1). In medaka embryos, tyrp1a 
expression occurs in the RPE and melanophores while tyrp1b is 
expressed only in melanophores. In zebrafish embryos, the duplicated 
tyrp1 genes exhibit overlapping expression in the RPE and 
melanophores, and knockdown of both tyrp1 genes leads to pigmentary 
defects (Braasch et al., 2009b). In this case, medaka adopts the DCD 
model, and zebrafish uses the DDC model as usual. It will be interesting 
to determine whether non-pigmentary genes also exhibit such a species-
specific difference in evolutionary divergence. 
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Approximately 30% of zebrafish genes are duplicates (Amores et al., 
1998; Postlethwait et al., 1998), their current co-existence may well be 
explained by the DDC model (Force et al., 1999). Evolution of many 
other gene duplicates must follow a different way, so that one copy can 
no longer be identified as a member of the gene pair. This copy may 
have undergone neofunctionalization or nonfunctionalization. During the 
past process of neofunctionalization or nonfunctionalization, the DCD 
model must have operated. Therefore, the DCD model used by the 
medaka mitf gene may represent an intermediate step for gene loss or 
neofunctionalization in the past, and towards gene loss or 
neofunctionalization in the future. During early stages of evolution, the 
DCD model might be insufficiently distinguishable to the DDC model 
because of remnant expression and/or function. 
4.3 AT and the role of mitf genes 
4.3.1 Conserved mechanism of AT of mitf  
Mitf is best known for its AT and AS. The human Mitf gene, for 
example, has 9 alternative promoters and first exons that are separately 
spliced to exons 2~9 (Hou and Pavan, 2008). A comparison of 
sequenced genomes has revealed that the conservation of these 9 
promoters and exons is limited to mammalian mitf genes (chimpanzee, 
mouse and rat), with the chicken mitf having only 3 of them (Hallsson et 
al., 2007). In fish, two mitf genes coexist which are the products of an 
ancient WGD event, and their protein products are equivalent to 2 of the 
mammalian isoforms. This has led to a notion that fish has evolved a 
genomic approach rather than alternative transcription to produce Mitf 
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proteins corresponding to mammalian Mitf isoforms (Altschmied et al., 
2002; Braasch et al., 2009a). In this study (Chapter 3.3), we reveal that 
medaka mitf1 has at least 5 alternative promoters for generating 5 
isoforms, providing first evidence that alternative transcription has also 
evolved in a fish mitf gene. The Drosophila mitf has two alternative 
promoters, which - in combination with alternative splicing – can produce 
up to 6 protein isoforms 
( http://asia.ensembl.org/Drosophila_melanogaster/Gene/Summary?g=FBgn0263
112&db=core ). We conclude that alternative transcription is a conserved 
mechanism of mitf expression in both invertebrates and vertebrates. 
4.3.2 Role of mitf due to differential expression or differential 
activity 
Mitf is a pleiotropic factor in mammals, coincident with wide 
expression of its transcripts in many types of cells. Differential 
expression of various Mitf isoforms has best been documented for 
ubiquitous MitfA and melanocyte-specific MitfM in mouse and human 
(Hou and Pavan, 2008). In this study, we reveal that the 5 Mitf1 isoforms 
possess considerably differential expression in adult organs and 
developing embryos. These results suggest that differential expression 
and its regulatory mechanism are conserved between fish and mammals. 
It has long been argued that the N-terminus may determine the activity 
of a particular Mitf isoform. It has been reported that the mast cell-
specific isoform MitfMC functions differently from the melanocyte-
specific isoform MitfM in its ability to activate cell type-specific target 
genes, because MitfMC functions only on a mast cell target promoter but 
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fails to activate, and even inhibit, a melanocyte target promoter despite 
binding to its E-box element (Takemoto et al., 2002). Data obtained in 
the present study corroborates and extends this report by showing that 
isoforms Mitf1A, Mtf1B, MitfH and Mitf1M possess different activities on 
activating target genes specific either to melanocytes or germ cells and 
on inducing melanocyte differentiation in ES cells. Most convincingly, we 
reveal that deletion of the N-terminus retains the ability to activate 
melanogenic expression but loses the capabilities of inducing 
melanocyte differentiation and activating germline genes’ expression, 
demonstrating the importance of the N-terminus in determining the 
activity and efficiency of major Mitf isoforms in different cell lineages. 
Our observations that major Mitf1 isoforms show clear differences in 
expression, activity and specificity offer new insights into the Mitf 
functions and phenotypes. Of the 5 Mitf1 isoforms analyzed in this study, 
for example, only Mitf1M is efficient in inducing melanogenesis target 
genes’ expression and melanocyte differentiation, whereas the 
remainder has no or little activity. This explains why the mitf transcripts 
are present in a wide variety of cells, and only a subset of which are or 
will become melanocytes. For example, we have recently reported that 
Mitf is a transcriptional activator of germline genes and that the gonadal 
expression of both medaka mitf genes is specific to germ cells as 
evidenced by in situ hybridization using riboprobes capable of detecting 
all RNA variants (Zhao et al., 2012). In this study, we reveal that the mitf1 
transcripts in the medaka gonads of both sexes are essentially variants 
for Mitf1A and Mitf1B, the former being incapable of, and latter being 
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inefficient, in melanocyte induction in the ES cell differentiation model. It 
is not surprising that medaka germ cells retain the germ cell identity while 
express a relatively high level of Mitf expression. This situation also 
applies similarly to cells in the brain, heart, spleen and liver where the 
Mitf1M-encoding variant is hardly detectable. 
Two organs of mesodermal origin do express the Mitf1M-encoding 
variant at a level comparable to that in the pigmentary organs (skin and 
eye). These are the kidney and muscle, which express also variants for 
Mitf1A and Mitf1B. This allows for two explanations. One is that the level 
of Mitf1M is insufficient for trans-differentiating muscles and kidney cells 
into melanocytes.  The other is an inhibitory effect of Mitf1A and/or 
Mitf1B on the melanocyte-inducing activity of Mitf1M. In support of the 
second possibility is the report that the mast cell-specific isoforms 
inhibits melanocytic gene expression (Takemoto et al., 2002). 
Unlike the mammalian pigmentary lineage comprising solely 
melanocytes, the medaka pigmentary lineage consists also of 
iridophores, leucophores and xanthophores besides melanophore 
(Kelsh et al., 2004). In this study, we observe that Mitf2M and all Mitf1 
isoforms but not Mitf1H are capable of activating the expression of 
xanthine dehydrogenase, a marker for xanthophores. This suggests a 
possible role for Mitf also in the development of this particular subtype 
of pigment cells. For zebrafish, the nacre mutation would also lead to 
reduction of xanthophores (Lister et al., 1999).  
Melanocyte development involves melanocytogenesis and 
melanogenesis. The former refers to melanocytic formation, proliferation 
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and survival, and latter is a process of melanin synthesis for black 
pigmentation. Mitf controls both melanocytic and melanogenic events. In 
this study, we reveal, for the first time to our knowledge, that melanocytic 
and melanogenic gene-regulating activities of a Mitf protein are 
separable. For example, Mitf1M, Mitf2M and Mitf1N are comparable in 
activating the melanogenic tyrosinase promoter but dramatically 
different in melanocyte induction. 
4.4 AS and the role of mitf genes 
Recent studies based on RNA-Seq have revealed the prevalence of 
alternative splicing across many species (Pan et al., 2008; Sultan et al., 
2008). This raises a question about the biological meaning of AS. For 
example, how many AS variants have functions?  In the scale of mRNA, 
many low-abundant AS variants are not conserved, as they are 
suggested to be a stochastic noise during transcription (Melamud and 
Moult, 2009). However, in other studies, people found that when an AS 
event is conserved, its change of mRNA length is much more likely that 
it can be directly divided by 3 (Xing and Lee, 2005). In this way, the 
addition or deletion of this part of mRNA will lead to the change of some 
amino acids while the translation of downstream proteins still remains 
unaffected. This ‘removable’ part is regarded as a ‘modular’ protein-
coding unit. However, the actual roles and mechanism of these modular 
exons in gene regulation and evolution still needs further demonstration. 
A study of AS in human MITF showed that one MitfM AS isoform that 
are 6 residues shorter than the normal one has differences in DNA 
binding efficiency (Bismuth et al., 2005). Another AS isoform of MITF-M, 
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called MITF-MDel, was recently reported to be expressed only in 
melanocytes and melanoma cells (Wang et al., 2010). This isoform that 
is spliced at exon 2 and 6 was predicted to be a prognostic biomarker 
for melanoma.  A more recent studies also identified an AS variant in 
melanoma cells with an 75 bp in-frame deletion in exon 2B for MITF-M 
(Simmons et al., 2014). In vivo study in the mice suggest an important 
role of exon 2 in melanoma progression and linking between AS and 
post-translational modifications (Debbache et al., 2012). All this AS 
studies are consistent with the concept of ‘modular’ protein-coding unit 
and are suggesting the role of some particular exons in gene regulation.  
In our study, the exon 5b of both mitf1 and mitf2 also fulfilled the 
situation that the lengths of the skipped exon were 96 and 84, which both 
can be divided by 3. However, after comparing the genomic organization 
of human and fish mitf genes, an interesting finding can be drawn that 
the exon 5b was only obtained in fish mitf genes. In this way, there was 
no conservation of this exon between human and fish. Another finding 
was that there was a conservation between medaka mitf genes 
themselves. These finding suggest a differential evolution of fish and 
human mitf genes after the WGD event and the exon 5b could be a 
modular protein-coding unit if we limit this concept only in medaka mitf. 
If AS evidence of mitf in other fish species could be provided, this 
phenomena could even likely to be conserved in fish species. For 
skipping of mitf2 exon 8, it did not fulfil this situation as the length of exon 
8 was 148. This means the downstream translation was affected due to 
non-synonymous mutations for mitf2Δ8 variant. 
  91
Apart from exon skipping, other AS events are also being studied. 
Researchers found that an insertion of long interspersed element-1 in 
the Mitf gene is associated with altered neurobehavior of the black-eyed  
white Mitf mi-bw mouse (Takeda et al., 2014) 
4.5 Conclusions 
This thesis has identified mitf1 and mitf2 differential evolution after 
WGD by examining divergent sequence, differential expression and 
differential activity. To further investigate into AT and AS of mitf genes, 
RACE (Rapid Amplification of cDNA Ends) and RNA-Seq were 
employed. We have identified 5 and 3 transcript variants of mitf1 via AT 
and AS, respectively. The results of RT-PCR prove differential 
expression of these mitf AT variants in different organs and stages of 
development. Isoforms predicted from these mitf1 AT variants differed 
dramatically in activating target gene expression. Intriguingly, these 
Mitf1 isoforms possess considerable differences in inducing the 
expression of multiple cell lineage marker genes. These results 
demonstrate that AT is a conserved mechanism controlling mitf 
expression in vertebrates ranging from human to fish, and that different 
Mitf AT isoforms possesses different activities. Interestingly, mitf2 has a 
single promoter and thus lacks AT but is able to produce 2 AS variants. 
We have also proven the differential expression of AS variants in both 
mitf1 and mitf2. Thus, the duplicated medaka mitf genes show a 
considerable difference in the retention and loss of AT and AS during 
their evolution. This finding sheds new lights on differential evolution 
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Table S1. PCR primers 





Name Sequence (bp) 
mitf gene 
mitf1 m1f1 GTAGATTACATCCGCAAGCTG 
501 
(ENSORLG00000013461) m1r1 ACAGCCCTGCTCGTTTTCATCCAT 
mitf2 m2f1 AGCTCCTGTGCATCTGGCATT 
201 
(ENSORLG00000003123) m2r1 GTTGAACCTTCGCCTTCGTT 
Neural crest 
sox10 Sox10-1 AAGCAGCAGCAGCATCACAG 
441 
(AJ410688) Sox10-2 CTGCTTCTGTGGTCTGATGT 
pax3 pax3ae2f TTCCCATGGTTGCGTGTCC 
247 
(ENSORLT00000011327) pax3ae4r ACTCCGCATCATGCGACTGA 
Melanophore 
tyra tyr882f CGCTGACGTAGAGTTCACCAT 
740 
(AB010101) tyr1621R TAGCCGTCATTGTGGCCAA 
tyrp1 Trp1b GATCGTGGATGATGATGTGG 
500 
(AF072305) Trp1c GCCCGAAGACGTCCGAGTA 
Iridophore 
pnp4a pnp4af AAGGACCACATCAACATGCC 
278 
(ENSORLT00000003413) pnp4ar ACCTCGTGGACTGTGCTCAT 
Xanophore 
xanthine dehydrogenase, xdh xdhf TCAGAGGTGGAGATTGACTG 
294 
(ENSORLT00000001340) xdhr CTTGGAGGCAAAGATGGCTT 
csf1r, receptor tyrosine kinase csf1raf GAGTGACGTCTGGTCTTACG 
355 
(ENSORLT00000006111) csf1rar GTCACAAGACTGGTCACAGG 
csf1rb csf1rbf CCTATTGGTCGTCCTCCACA 
574 
(ENSORLT00000016041) csf1rbr TTCGGAGCAGCAGGAAATCC 
Schwan cell  
erbb3a Erbb31 TTGGGGACCAAACGAGCATC 
302 
(AF072310) Erbb32 CAAAATGAGTGGGACATTGAG 
Cartilage  
cart1  cart1f CCATGAGGACAGAGTTGACG 
360 
(ENSORLT00000003318) cart1r AGTTGTTCAAGGAGACGTGG 
Heart  
nkx2.5 nkx2.5f CGTCACATCTATGTTTGGGG 
557 
(NM_001104912 ) nkx2.5r TGTTGTAGGTGAAGTGGCTG 
Muscle  
myosin chain myhl1f CAAGAAGCAGCTCCAGAAAC 
398 
(ENSORLG00000018530) myhl1r GGACATATGAGCTTTACTCAGC 
actinin2 actn2-1 GTATAATGATTCTGGTGGATCC 
288 
(ENSORLG00000005187 actn2-2 CATAGAGGGCAGTAGAGAATGC 
Tumor 
suppresor 
p53 p53ex6f CTGTGGAGCACCGAAGCCATC 
500 
(OLU57306) p53cdsR ATTGCTCTTCAGCTTCTTCCCA 
  104
Germ cell 
Dazl DazlF AATACCTTCATCATCCTCACCTC 
328 
(AY973274) DazlR AAGTGAAGGAACGTTTGACC 
Vasa VasaF CGTCCAGCACGTGGTGAACT 
486 
(NM_001104676) VasaR TTCCGGACTTGAACGTGGG 
Mast cell 
Tryptase trpf GCTCCATCATCACACAGAAC 
362 
(ENSORLT00000008267) trpr CTTCACTTCCTGTAGAGTCC 
Neural 
ectoderm 
pax6 pax6af GCGAAAGCCTACATTTTATC 
397 
(AJ000938) pax6ar CGCAAAGATAGACGGACACT 
rx3 rx3f CGAACCACCTTTACCACATAC 
396 
(AJ298300 ) rx3r TAAGGAGGTCGGCAAGGAAG 
Endoderm  
sox17 sox17a ATGAGTAGTCCCGATGCGGG 
450 
(ENSORLG00000011542) sox17b GCCGGAGTCCAGCCTCTTAAT 
hnf3b hnf3a ATGATGCTTGGAGCAGTTAA 
800 
(NM_001104692)  hnf3b CTACGAGGAGTTCATGATTG 
House 
keeping 
β-actin AM1 TTTCAACAGCCCTGCCATGTAC 
651 






Table S2. ddPCR primers 
 
Gene  
Primer Size  





























mitf1∆e288 Mitf1de288F GCTTCCCTGTTGAAGCTGAG 176 
Mitf1dR CTTCAGGATGGTGCCTTTGT 
mitf1∆5b Mitf1d5bF GAATACTCAGAAGCTGAGGTAAGAGC 
177 
Mitf1dR CTTCAGGATGGTGCCTTTGT 
mitf2m Mitf2mF AACAGCTCCTGGCATGAAG 
242 
Mitf2mR CCTTGTTCCAGCGCATATCT 
mitf2∆5b 
Mitf2d5bF ATTAACAGAGACTGAGGTTAGAGCTCTT 
243 
Mitf2mR CCTTGTTCCAGCGCATATCT 
mitf2∆8 
Mitf2mF AACAGCTCCTGGCATGAAG 
235 
Mitf2d8R GGATCTCAAGTTCGGATCATTG 
β-actin 
actinQF AGAAGAGCTATGAGCTGCCTG 
151 
actinQR AACATCACACTTCATGATGCTG 
